<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">Regulation of the Activity of the Dual Leucine Zipper Kinase by Distinct Mechanisms</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
				<date type="published" when="2024-02-11">11 February 2024</date>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName><forename type="first">Kyra-Alexandra</forename><surname>Köster</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Clinical Pharmacology and Toxicology</orgName>
								<orgName type="institution">University Medical Centre Hamburg-Eppendorf</orgName>
								<address>
									<postCode>20246</postCode>
									<settlement>Hamburg</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="institution">DZHK Standort Hamburg</orgName>
								<address>
									<settlement>Kiel, Lübeck</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Marten</forename><surname>Dethlefs</surname></persName>
							<email>m.dethlefs.ext@uke.de</email>
							<idno type="ORCID">0009-0001-0921-7295</idno>
							<affiliation key="aff0">
								<orgName type="department">Department of Clinical Pharmacology and Toxicology</orgName>
								<orgName type="institution">University Medical Centre Hamburg-Eppendorf</orgName>
								<address>
									<postCode>20246</postCode>
									<settlement>Hamburg</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="institution">DZHK Standort Hamburg</orgName>
								<address>
									<settlement>Kiel, Lübeck</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Jorge</forename><surname>Duque Escobar</surname></persName>
							<email>j.duque-escobar@uke.de</email>
							<idno type="ORCID">0000-0002-6215-1555</idno>
							<affiliation key="aff1">
								<orgName type="institution">DZHK Standort Hamburg</orgName>
								<address>
									<settlement>Kiel, Lübeck</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff2">
								<orgName type="department" key="dep1">University Center of Cardiovascular Science</orgName>
								<orgName type="department" key="dep2">Department of Cardiology</orgName>
								<orgName type="institution" key="instit1">University Heart &amp; Vascular Center Hamburg</orgName>
								<orgName type="institution" key="instit2">University Medical Center Hamburg-Eppendorf</orgName>
								<address>
									<postCode>20246</postCode>
									<settlement>Hamburg</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Elke</forename><surname>Oetjen</surname></persName>
							<email>e.oetjen@uke.uni-hamburg.de</email>
							<idno type="ORCID">0000-0001-7807-6652</idno>
							<affiliation key="aff0">
								<orgName type="department">Department of Clinical Pharmacology and Toxicology</orgName>
								<orgName type="institution">University Medical Centre Hamburg-Eppendorf</orgName>
								<address>
									<postCode>20246</postCode>
									<settlement>Hamburg</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="institution">DZHK Standort Hamburg</orgName>
								<address>
									<settlement>Kiel, Lübeck</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff3">
								<orgName type="department">Institute of Pharmacy</orgName>
								<orgName type="institution">University of Hamburg</orgName>
								<address>
									<postCode>20146</postCode>
									<settlement>Hamburg</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">Regulation of the Activity of the Dual Leucine Zipper Kinase by Distinct Mechanisms</title>
					</analytic>
					<monogr>
						<imprint>
							<date type="published" when="2024-02-11">11 February 2024</date>
						</imprint>
					</monogr>
					<idno type="MD5">196718DD72587A030CE75AE3E04509E8</idno>
					<idno type="DOI">10.3390/cells13040333</idno>
					<note type="submission">Received: 29 December 2023 Revised: 5 February 2024 Accepted: 7 February 2024</note>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.8.0" ident="GROBID" when="2024-05-25T07:16+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<textClass>
				<keywords>
					<term>dual leucine zipper kinase</term>
					<term>phosphorylation</term>
					<term>protein-protein interaction</term>
					<term>proteasomal degradation</term>
					<term>palmitoylation</term>
				</keywords>
			</textClass>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0"><p>The dual leucine zipper kinase (DLK) alias mitogen-activated protein 3 kinase 12 (MAP3K12) has gained much attention in recent years. DLK belongs to the mixed lineage kinases, characterized by homology to serine/threonine and tyrosine kinase, but exerts serine/threonine kinase activity. DLK has been implicated in many diseases, including several neurodegenerative diseases, glaucoma, and diabetes mellitus. As a MAP3K, it is generally assumed that DLK becomes phosphorylated and activated by upstream signals and phosphorylates and activates itself, the downstream serine/threonine MAP2K, and, ultimately, MAPK. In addition, other mechanisms such as protein-protein interactions, proteasomal degradation, dephosphorylation by various phosphatases, palmitoylation, and subcellular localization have been shown to be involved in the regulation of DLK activity or its fine-tuning. In the present review, the diverse mechanisms regulating DLK activity will be summarized to provide better insights into DLK action and, possibly, new targets to modulate DLK function.</p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="1.">(Patho)physiological Actions of DLK</head><p>The dual leucine zipper kinase (DLK) alias mitogen-activated protein 3 kinase 12 (MAP3K12) has gained much attention in recent years due to its involvement in several neurodegenerative diseases such as amyotrophic lateral sclerosis (ALS), Parkinson's disease and Alzheimer's disease <ref type="bibr" target="#b0">[1]</ref><ref type="bibr" target="#b1">[2]</ref><ref type="bibr" target="#b2">[3]</ref><ref type="bibr" target="#b3">[4]</ref><ref type="bibr" target="#b4">[5]</ref><ref type="bibr" target="#b5">[6]</ref>, and glaucoma <ref type="bibr" target="#b6">[7]</ref> (Table <ref type="table" target="#tab_0">1</ref>). In an insulin-producing betacell line, DLK was shown to become activated by prodiabetogenic signals, inhibit insulin synthesis and secretion, and induce apoptosis, thus promoting the pathogenesis of diabetes mellitus type 2 <ref type="bibr" target="#b7">[8]</ref><ref type="bibr">[9]</ref><ref type="bibr" target="#b9">[10]</ref><ref type="bibr" target="#b10">[11]</ref><ref type="bibr" target="#b11">[12]</ref><ref type="bibr">[13]</ref>. Furthermore, in the next-generation sequencing data set GSE81608, the upregulation of MAP3K12 was observed in the islets of type 2 diabetic patients in comparison to healthy donors <ref type="bibr" target="#b13">[14]</ref>, and in a genome-wide association study, the SNV rs77511173-C (location 12.53489753) within MAP3K12 was associated with body mass index in a Japanese population <ref type="bibr" target="#b14">[15]</ref>. However, in a rat model, DLK was required for postnatal beta-cell proliferation <ref type="bibr" target="#b15">[16]</ref>. Thus, DLK might be important for the development of the neuronal system <ref type="bibr" target="#b16">[17]</ref> and early postnatal beta-cells <ref type="bibr" target="#b15">[16]</ref>. Deletion or inhibition of DLK reduced p-c-Jun; protected against axon degeneration, neuronal loss, and functional decline; and improved survival of SOD1 G93A mice. p-JNK and p-c-Jun were elevated in patient lumbar spinal cord lysates.</p><p>[1]</p><p>Alzheimer's disease (AD) Mouse Human tissue (postmortem) PS2APP Tau P301L  AD patients' brain Deletion of DLK reduced p-c-Jun in immunoblot and immunochemistry and improved preserved cognitive function. P-c-Jun was detected in dentate gyrus via immunohistochemistry.</p><p>[1]</p><p>Human ESC-derived cortical neurons Mouse ApoE2, ApoE3, ApoE4 treatment ApoE increased DLK, while ApoE3 slowed DLK protein turnover rate. <ref type="bibr" target="#b1">[2]</ref> Mouse primary hippocampal and cortical neurons Overexpression of human tau DLK inhibition reduced p-JNK and p-c-Jun and cytotoxicity <ref type="bibr" target="#b5">[6,</ref><ref type="bibr" target="#b20">21]</ref> Mouse APP/PS1 mouse model Downregulation of DLK by MiR-191-5p inhibited Amyloid-beta-induced microglial cell injury. <ref type="bibr" target="#b21">[22]</ref> Parkinson's disease (PD) Mouse 6OHDA (neurotoxin) (intra-striatal)</p><p>AAV-directed expression of d/n-DLK (K152A) had anti-apoptotic and trophic effects on dopaminergic neurons. <ref type="bibr" target="#b22">[23]</ref> Mouse MPTP (mitochondrial toxin)</p><p>DLK inhibition suppressed c-Jun phosphorylation in dopaminergic neurons of the substantia nigra. <ref type="bibr" target="#b23">[24]</ref> Traumatic brain injury Mouse Impact acceleration</p><p>Injury activated the DLK-JNK axis in retinas, while DLK deletion blunted c-Jun-phosphorylation. <ref type="bibr" target="#b24">[25]</ref> Traumatic brain injury (subarachnoid hemorrhage)</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Rat</head><p>Endovascular perforation DLK silencing attenuated brain edema and neuronal apoptosis and improved neurobehavioral functions. DLK overexpression deteriorated neurobehavioral functions and brain edema.</p><p>[26]</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Rat Endovascular perforation</head><p>Tozasertib reduced neuronal apoptosis, and p-JNK attenuated brain edema and improved neurobehavioral deficits. <ref type="bibr" target="#b26">[27]</ref> Stroke/traumatic brain injury Mouse Photothrombosis-induced focal cortical stroke Knockdown of post-stroke upregulated protein CCR5 inhibited DLK expression. <ref type="bibr" target="#b27">[28]</ref> Cells 2024, 13, 333  [44]</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Mouse primary RGCs</head><p>Colchicine 1 µM Glaucoma Increased survival of RGCs. <ref type="bibr" target="#b45">[46]</ref> The reactivation of latent neuronal herpes simplex virus (HSV) infections can cause, besides blisters and sores, severe encephalitis, and it is triggered by neuronal stress. By inducing the initial wave of the increased expression of lytic genes, DLK mediates the reactivation of latent HSV infection in different model systems <ref type="bibr" target="#b36">[37,</ref><ref type="bibr">39,</ref><ref type="bibr" target="#b46">47]</ref>. In addition, an association of DLK with different kinds of cancer was found, whereby DLK mRNA expression was positively correlated with lung adenocarcinoma, pancreatic duct adenocarcinoma, sarcoma, and thymoma. The survival rates in kidney renal clear cell carcinoma, kidney renal papillary cell carcinoma, pheochromocytoma, paraganglioma, stomach adenocarcinoma, and uterine corpus endometrial carcinoma were all negatively associated with DLK mRNA expression <ref type="bibr" target="#b47">[48]</ref>. In prostate cancer cells, DLK was shown to regulate proliferation and invasion <ref type="bibr" target="#b48">[49]</ref>. Thus, the inhibition of DLK is supposed to be a promising drug target for the treatment of several neurodegenerative diseases and, possibly, diabetes. Indeed, some DLK inhibitors have been developed and already tested in vitro and in vivo, and sunitinib and tozasertib have been re-purposed as DLK inhibitors but are in fact multi-kinase inhibitors (Table <ref type="table" target="#tab_1">2</ref>). However, in a phase-1 with patients suffering from ALS treated with GDC-0134, an unexpected increase in a putative ALS biomarker was observed, and no tolerable dose could be found <ref type="bibr" target="#b3">[4]</ref>. The development of the DLK inhibitor IACS-52825 was stopped due to dose-independent reversible optic nerve swelling in monkeys <ref type="bibr" target="#b49">[50]</ref>.</p><p>DLK belongs to the class of the mixed lineage kinases (MLK), characterized by sequence homology to both serine/threonine and tyrosine kinases in their primary structure, but functioning as serine/threonine kinase <ref type="bibr" target="#b46">[47]</ref><ref type="bibr" target="#b47">[48]</ref><ref type="bibr" target="#b48">[49]</ref>. The class of the MLK can be subdivided into three subclasses: The largest class consists of MLK1-4 (MAP3K9-11 and 21, respectively), sharing 75% sequence identity in their kinases domains and displaying an amino-terminal SH3 domain, followed by the kinase domain, a leucine zipper, the Cdc42/Rac Interacting Binding (CRIB) motif, and a large C-terminal region. Another subgroup consists of the leucine zipper and sterile-alpha motifs (SAM) ZAK or MLK7 (MAP3K20), containing the dimerizing SAM in addition to the leucine zipper domain. DLK forms another MLK subgroup with the leucine zipper kinase (LZK; MAP3K13). The kinases share 90% amino acid sequence identity within their enzymatic and dual leucine zipper domain (Figure <ref type="figure" target="#fig_0">1</ref>).</p><p>DLK belongs to the class of the mixed lineage kinases (MLK), characterized by sequence homology to both serine/threonine and tyrosine kinases in their primary structure, but functioning as serine/threonine kinase <ref type="bibr" target="#b46">[47]</ref><ref type="bibr" target="#b47">[48]</ref><ref type="bibr" target="#b48">[49]</ref>. The class of the MLK can be subdivided into three subclasses: The largest class consists of MLK1-4 (MAP3K9-11 and 21, respectively), sharing 75% sequence identity in their kinases domains and displaying an amino-terminal SH3 domain, followed by the kinase domain, a leucine zipper, the Cdc42/Rac Interacting Binding (CRIB) motif, and a large C-terminal region. Another subgroup consists of the leucine zipper and sterile-alpha motifs (SAM) ZAK or MLK7 (MAP3K20), containing the dimerizing SAM in addition to the leucine zipper domain. DLK forms another MLK subgroup with the leucine zipper kinase (LZK; MAP3K13). The kinases share 90% amino acid sequence identity within their enzymatic and dual leucine zipper domain (Figure <ref type="figure" target="#fig_0">1</ref>).  DLK and LZK are highly conserved orthologues of Wallenda/DLK in Drosophila melanogaster and DLK-1 in Caenorhabditis elegans, suggesting an important role for DLK in evolution and development. Indeed, while mice lacking Mlk1, Mlk2, Mlk3, or Lzk are viable <ref type="bibr" target="#b47">[48,</ref><ref type="bibr" target="#b49">50,</ref><ref type="bibr" target="#b50">51]</ref>, mice lacking Dlk die perinatally and show signs of impaired neuronal development <ref type="bibr" target="#b16">[17]</ref>. In line with this finding, the genome aggregation database (gnomAD v 2.1), a repository of data on human genes and their single-nucleotide variants (SNV), calculated for the MAP3K12 (gene) 41.3 loss of function (LoF) SNV but observed none of them in their different cohorts. Thus, in species as diverse as mice and humans, intact DLK appears to be essential for prenatal development. Yet, the conditional deletion of Dlk in mice aged 10 to 12 weeks did not result in gross phenotypic changes, suggesting that in adults, the absence of DLK or its function does not interfere with vital functions under normal conditions <ref type="bibr" target="#b17">[18]</ref>. The inhibition of DLK has been proposed as a promising drug target to treat neurodegenerative diseases like amyotrophic lateral sclerosis, Alzheimer's disease, Parkinson's disease <ref type="bibr" target="#b0">[1,</ref><ref type="bibr" target="#b1">2,</ref><ref type="bibr" target="#b3">4]</ref>, glaucoma <ref type="bibr" target="#b6">[7]</ref>, and diabetes mellitus type 2 <ref type="bibr" target="#b7">[8]</ref><ref type="bibr">[9]</ref><ref type="bibr" target="#b9">[10]</ref>. This suggests that abnormal DLK activity in adults contributes to pathological signaling in various tissues. However, DLK signaling is required for the induction of the pro-regenerative transcriptional program in peripheral nerves after injury <ref type="bibr" target="#b51">[52,</ref><ref type="bibr" target="#b52">53]</ref>, and it has been shown to be constitutively active in the adult mouse brain, exerting both homeostatic and stress-induced functions <ref type="bibr" target="#b2">[3]</ref>. These findings suggest that DLK indeed acts as a "double-edged sword" <ref type="bibr" target="#b53">[54]</ref>. Acting as a MAP3K, DLK mainly activates the MAP2Ks MKK4 and MKK7, leading to the phosphorylation and activation of the MAPK c-Jun N-terminal kinase (JNK) <ref type="bibr" target="#b54">[55]</ref>. In a refined model, DLK under basal conditions is tethered to the scaffold protein JNK-interacting protein/Islet Brain 1 (JIP/IB1), rendering the kinase inactive. Upon the phosphorylation of JIP/IB1 by JNK on Thr103, DLK dissociates from the scaffold, homodimerizes, autophosphorylates in trans, and becomes active <ref type="bibr" target="#b55">[56]</ref><ref type="bibr" target="#b56">[57]</ref><ref type="bibr" target="#b57">[58]</ref><ref type="bibr" target="#b58">[59]</ref>. This model implies that activation of JNK leads to the activation of DLK, which, in turn, stimulates JNK activity, thereby amplifying possibly cell-toxic signals. In addition to activating JNK and being (indirectly) activated by Cells 2024, 13, 333 6 of 18 this kinase, DLK also activates other MAPKs <ref type="bibr" target="#b1">[2]</ref>. Furthermore, different post-translational modifications that might result in DLK's proteasomal degradation or enhanced protein stability, protein-protein interactions, subcellular localization, and microRNAs contribute to DLK activity. To better understand DLK function and the regulation of its activity, this review summarizes the regulation of DLK activity via various mechanisms at transcriptional, translational, and post-translational levels.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.">Regulation of DLK</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.1.">Regulation of DLK at the Transcriptional Level</head><p>Not much is known about the regulation of the DLK gene expression: The TATAbox-the less core promoter regions of human and mouse DLK gene upstream of exon 1 share 88% identity with completely conserved xenobiotic responsive element-like sites, GC-boxes, and exon 1 in between both species. Using electrophoretic mobility shift assays (EMSA) and reporter gene assays with 5 ′ -deleted promoter fragments, the transcription Sp3 factor was shown to bind to and activate the core promoter in the human neuroblastoma cell line SH-SY5Y <ref type="bibr" target="#b59">[60]</ref>. In the 3T3-L1 cell line, the ligand of the peroxisome-proliferatoractivated receptor γ (PPARγ) rosiglitazone increased DLK expression, whereas the inhibition of PPARγ either by small hairpin RNA or the receptor antagonist GW9662 suppressed DLK protein and mRNA expression. Two binding-sites for PPARγ and its heterodimer retinoic X receptor were identified via EMSA and chromatin immunoprecipitation assays <ref type="bibr" target="#b60">[61]</ref>. In human adipose stromal/stem cells, precursors of mature adipocytes, and bisphenol A increased DLK expression, presumably after binding to estrogen receptors <ref type="bibr" target="#b61">[62]</ref>, but it was not investigated whether the DLK promoter contained an estrogen receptor responsive element. Thus, DLK gene expression is regulated by Sp3, the nuclear receptors PPARγ, and the estrogen receptor. Of note, DLK itself has been shown to increase PPARγ gene expression in 3T3-L1 and adipose stromal/stem cells <ref type="bibr" target="#b61">[62,</ref><ref type="bibr" target="#b62">63]</ref>. Finally, reduced Dlk expression was observed in the lenses of mice deficient in the transcription factors Mafg and Mafk <ref type="bibr" target="#b63">[64]</ref>, suggesting that these transcription factors may be involved in Dlk expression.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.2.">Regulation of DLK at the Post-Transcriptional Level</head><p>The human MAP3K12 gene spans 21.871 nucleotides (nt) and is located on the complementary strand of chromosome 12, GRCh38.p14 Primary Assembly. It is flanked by the gene encoding for the TARBP2 subunit of the RISC loading complex (TARBP2) and the poly(rC) binding protein 2 (PCBP2) gene, both located on the positive strand in opposite directions relative to the DLK gene. The transcripts of the human DLK Isoforms 1 (NM_001193511.2) and 2 (NM_006301.4) differ in a 99 nt stretch that is absent in Isoform 2, resulting in a slightly shorter protein of 859 amino acids (aa) and a calculated molecular weight of 93.2 kDa, instead of 892 aa and 96.3 kDa (NCBI, https://www.ncbi.nlm.nih.gov/gene/7786, 30 June 2023, 14:33. conserved) (Figure <ref type="figure" target="#fig_3">2</ref>).</p><p>In various additional model organisms, different isoforms of DLK are expressed, probably due to differential splicing (Table <ref type="table" target="#tab_3">3</ref>). Of note, only Isoform D of Wallenda differs at the protein level from isoforms A, B, and C.</p><p>It is not known how differential splicing of DLK RNA is regulated and whether the isoforms or aberrant splice isoforms exert distinct functions or are differentially expressed in tissues or diseases. An exception is the C. elegans DLK-1 gene <ref type="bibr" target="#b64">[65]</ref>. DLK-1S (short isoform of DLK-1) interacts with DLK-1L (long isoform), restraining DLK-1L activity. An increase in calcium induces the homodimerization of DLK-1L and its activation, whereby a hexapeptide within the C-terminus of DLK-1L is essential for DLK-1L activity. However, the mammalian homolog of DLK-1 is MAP3K13 (LZK) <ref type="bibr" target="#b64">[65]</ref>, and although MAP3K13 and MAP3K12 share a high sequence identity in their catalytic and leucine zipper domains (Figure <ref type="figure" target="#fig_0">1</ref>), this hexapeptide is not conserved in MAP3K12, making the same kind of regulation described for DLK-1 unlikely to occur for DLK.  In various additional model organisms, different isoforms of DLK are expressed, probably due to differential splicing (Table <ref type="table" target="#tab_3">3</ref>). Of note, only Isoform D of Wallenda differs at the protein level from isoforms A, B, and C.   MicroRNAs (miRNAs) provide another mechanism for regulating gene expression at the post-transcriptional level. MiRNAs are small non-coding RNAs of about 22 nucleotides. By directing the RNA-induced silencing complex (RISC) to specific target mRNAs, miRNA can repress target genes and affect various biological responses <ref type="bibr" target="#b65">[66]</ref>. In turn, the expression of miRNAs is regulated by several physiological and pathophysiological conditions. DLK mRNA is predicted to be a target for miRNAs (TargetScan v8.0; targetscan.org) <ref type="bibr" target="#b66">[67]</ref>, and several interactions have been validated experimentally (miRTarBase) <ref type="bibr" target="#b67">[68]</ref>. In neuroblasts, the downregulation of the entire miR-17 family during neuronal differentiation and upregulation of DLK mRNA was observed, and the overexpression of miR-17 and miR-20a reduced DLK mRNA <ref type="bibr" target="#b68">[69]</ref>. In endothelial progenitor cells (EPC) from type 2 diabetic patients, the expression of miRNA-130a was reduced, and increased DLK expression was observed compared to EPC from healthy controls. In line with this finding, the overexpression of miRNA-130a decreased DLK protein expression in EPC, suggesting that DLK expression is regulated by miRNA-130a <ref type="bibr" target="#b69">[70]</ref>. The regulation of DLK via miRNA was also demonstrated in a mouse model of Alzheimer's disease (AD). MicroRNA-191-5p was shown to target the 3 ′ -untranslated region of MAP3K12, downregulating DLK expression and alleviating microglial cell injury in the AD mouse model <ref type="bibr" target="#b21">[22]</ref>. Yu et al. found, in various prostate cancer cell lines, that the tumor suppressor miR-150-5p downregulates MAP3K12 <ref type="bibr" target="#b70">[71]</ref>. These studies show that DLK expression is subject to miRNA regulation. Of note, miRNAs commonly target mRNAs of several proteins, so it is to be expected that a given miRNA downregulates more proteins than DLK only. Already, the first studies on DLK showed that this kinase is heavily phosphorylated, and the overexpression of DLK alone is sufficient to activate this kinase <ref type="bibr" target="#b46">[47,</ref><ref type="bibr" target="#b71">72]</ref>. At least some phosphorylation sites and DLK phosphorylating kinases have been identified in the meantime. Upon homodimerization via its leucine zipper domains, DLK becomes auto-phosphorylated in trans at Ser-302 (Figure <ref type="figure" target="#fig_7">3B</ref>) <ref type="bibr" target="#b10">[11,</ref><ref type="bibr" target="#b55">56,</ref><ref type="bibr" target="#b72">73]</ref>. Indeed, the phosphorylation occurring at this residue is crucial for DLK activation, since the mutation of Ser-302 renders the kinase inactive <ref type="bibr" target="#b10">[11,</ref><ref type="bibr" target="#b72">73]</ref>. Hence, phosphorylation at this residue is a prerequisite for DLK activation and can serve as a marker for DLK activity <ref type="bibr" target="#b9">[10,</ref><ref type="bibr" target="#b10">11,</ref><ref type="bibr" target="#b73">74]</ref>. In addition to DLK, protein kinase A (PKA) phosphorylates DLK at Ser-302 and activates the kinase, linking DLK to the evolutionary conserved mechanism of cyclic AMP-induced axonal regeneration in two mammals, D. melanogaster and C. elegans <ref type="bibr" target="#b73">[74,</ref><ref type="bibr" target="#b74">75]</ref> (Figure <ref type="figure" target="#fig_7">3B</ref>). Furthermore, DLK is a substrate for its non-downstream kinase JNK: using stable isotope labeling with amino acids in the HEK 293T cell line (SILAC), followed by mass spectrometry analysis, Huntwork-Rodriguez et al. (2013) identified Thr-43 and Ser-533 as residues that are phosphorylated by JNK (Figure <ref type="figure" target="#fig_7">3B</ref>). These findings were confirmed in a murine model of neuronal stress. Phosphorylations at these residues prevent the interaction of DLK with the E3 ubiquitin ligase Pam/Highwire/RPM-1 (PHR), thus stabilizing DLK (Figure <ref type="figure" target="#fig_7">3A</ref>) <ref type="bibr" target="#b72">[73]</ref>. In an attempt to identify kinases that activate neurodegenerative DLK/JNK signaling in neurons, the inhibition of the MAP4K subfamily of germinal center kinase-IV (GCK-IV), MAP4K4, mis-shapen-like kinase 1 (MINK, MAP4K6), and Traf2-and Nck-interacting kinases (TNIK, MAP4K7) reduced DLK activa- Indeed, the phosphorylation occurring at this residue is crucial for DLK activation, since the mutation of Ser-302 renders the kinase inactive <ref type="bibr" target="#b10">[11,</ref><ref type="bibr" target="#b72">73]</ref>. Hence, phosphorylation at this residue is a prerequisite for DLK activation and can serve as a marker for DLK activity <ref type="bibr" target="#b9">[10,</ref><ref type="bibr" target="#b10">11,</ref><ref type="bibr" target="#b73">74]</ref>. In addition to DLK, protein kinase A (PKA) phosphorylates DLK at Ser-302 and activates the kinase, linking DLK to the evolutionary conserved mechanism of cyclic AMP-induced axonal regeneration in two mammals, D. melanogaster and C. elegans <ref type="bibr" target="#b73">[74,</ref><ref type="bibr" target="#b74">75]</ref> (Figure <ref type="figure" target="#fig_7">3B</ref>). Furthermore, DLK is a substrate for its non-downstream kinase JNK: using stable isotope labeling with amino acids in the HEK 293T cell line (SILAC), followed by mass spectrometry analysis, Huntwork-Rodriguez et al. (2013) identified Thr-43 and Ser-533 as residues that are phosphorylated by JNK (Figure <ref type="figure" target="#fig_7">3B</ref>). These findings were confirmed in a murine model of neuronal stress. Phosphorylations at these residues prevent the interaction of DLK with the E3 ubiquitin ligase Pam/Highwire/RPM-1 (PHR), thus stabilizing DLK (Figure <ref type="figure" target="#fig_7">3A</ref>) <ref type="bibr" target="#b72">[73]</ref>. In an attempt to identify kinases that activate neurodegenerative DLK/JNK signaling in neurons, the inhibition of the MAP4K subfamily of germinal center kinase-IV (GCK-IV), MAP4K4, mis-shapen-like kinase 1 (MINK, MAP4K6), and Traf2-and Nck-interacting kinases (TNIK, MAP4K7) reduced DLK activation, phosphorylation on Thr-43, and protein stability upon nerve growth factor (NGF) withdrawal in murine dorsal root ganglia (Figure <ref type="figure" target="#fig_7">3B</ref>). However, the combined knock-down of all three MAP4Ks was needed to protect against NGF-withdrawal-induced DLK/JNK signaling <ref type="bibr" target="#b32">[33]</ref>. Using the optic nerve crush model, inhibitors of the GCK-IV kinase family enhanced the survival of retinal ganglia cells but, in contrast to DLK inhibition, did not interfere with axon regeneration <ref type="bibr" target="#b75">[76]</ref>. Notably, the overexpression of MAP4K3 (hematopoietic progenitor kinase 1, HPK1), shown to activate JNK signaling <ref type="bibr" target="#b76">[77]</ref>, phosphorylated MLK3 on Ser-281, corresponding to Ser-302 in DLK <ref type="bibr" target="#b77">[78]</ref>. Thus, at least some MAP4K might activate DLK, but not all functions of DLK overlap with those of MAP4K, suggesting additional upstream signals for DLK or an additional regulation of DLK action via other mechanisms, such as (tissue-dependent) dephosphorylation, (tissue-dependent) interaction with various scaffolds or other proteins, palmitoylation, or changing DLK subcellular localization <ref type="bibr" target="#b2">[3,</ref><ref type="bibr" target="#b4">5,</ref><ref type="bibr">9,</ref><ref type="bibr" target="#b9">10,</ref><ref type="bibr" target="#b71">72,</ref><ref type="bibr" target="#b72">73,</ref><ref type="bibr" target="#b78">[79]</ref><ref type="bibr" target="#b79">[80]</ref><ref type="bibr" target="#b80">[81]</ref><ref type="bibr" target="#b81">[82]</ref>. The study of <ref type="bibr" target="#b82">Daviau et al. (2009)</ref> indicates that DLK might also be activated via tyrosine phosphorylation and, thus, involved in a separate pathway. Various experiments showed that platelet-derived growth factor (PDGF) induced tyrosine phosphorylation and subsequent activation of DLK, which was dependent on the cytosolic tyrosine kinase Src. The PDGFdependent phosphorylation and activation of ERK and Akt was abolished via the RNA silencing of DLK and rescued via the re-introduction of recombinant wild-type DLK, suggesting that PDGF signal propagation depends on DLK. However, the tyrosine residue within DLK phosphorylated by PDGF-induced signaling was not identified <ref type="bibr" target="#b82">[83]</ref>. So far, the phosphorylation of DLK that has been described involved activating phosphorylation. In mouse embryonic stem cells, two Akt phosphorylation sites within DLK, Ser584 and Thr659 in murine DLK, were identified. The Akt-induced phosphorylation of these residues reduced DLK kinase activity, whereas the overexpression of these DLK mutants rendered the kinase more active, suppressing the self-renewal of mouse embryonic stem cells <ref type="bibr" target="#b83">[84]</ref>.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.3.2.">Dephosphorylation of DLK</head><p>Kinase-phosphatase interactions are a well-known component of cellular responses and signaling pathways, affecting kinase phosphorylation, expression levels, and interactions with other proteins. In invertebrates, DLK activity has been shown to be regulated by the protein phosphatases Mg 2+ /Mn 2+ dependent (PPM)-1 and PPM-2, as well as the protein phosphatase 2A (PP2A) <ref type="bibr" target="#b4">[5,</ref><ref type="bibr" target="#b84">85,</ref><ref type="bibr" target="#b85">86]</ref>. In mammals, the inhibition of protein phosphatases 2A <ref type="bibr" target="#b4">[5,</ref><ref type="bibr" target="#b71">72,</ref><ref type="bibr" target="#b82">83]</ref> and 2B <ref type="bibr" target="#b9">[10,</ref><ref type="bibr" target="#b11">12,</ref><ref type="bibr" target="#b71">72,</ref><ref type="bibr" target="#b86">87]</ref> affected DLK activity.</p><p>Several studies described the roles of the PHR proteins as key regulators of presynaptic differentiation and function, thereby fundamentally affecting neuronal development <ref type="bibr" target="#b87">[88]</ref><ref type="bibr" target="#b88">[89]</ref><ref type="bibr" target="#b89">[90]</ref>. Among the PHR proteins, the Regulator of Presynaptic Morphology (RPM)-1 has been shown to negatively regulate DLK-1 as part of an ubiquitin ligase complex in C. elegans <ref type="bibr" target="#b90">[91,</ref><ref type="bibr" target="#b91">92]</ref>. In 2011, Tulgren et al. provided additional evidence that PPM-1, a serine/threonine phosphatase homologous to human PPM1A, acts as a second negative regulatory mechanism downstream of RPM-1 to control the DLK-1 pathway in C. elegans <ref type="bibr" target="#b84">[85]</ref>. However, the involvement of PPM-1 was shown to act at the level of PMK-3 (p38 MAPK) and not directly at the level of DLK-1 (MAPKKK), as previously described by Takekawa et al. in mammalian cells <ref type="bibr" target="#b92">[93]</ref>. In contrast, the serine/threonine Protein Phosphatase Magnesium/Manganese-dependent 2 (PPM-2) has been described in transgenic animals, genetic, and biochemical approaches for directly regulating DLK-1 <ref type="bibr" target="#b85">[86]</ref>. <ref type="bibr" target="#b85">Baker et al. (2014)</ref> demonstrated that PPM-2 acts on DLK-1 at the Ser-874, regulating its phosphorylation and activation. However, the authors note that the activation of RPM-1 is a prerequisite for the activity of PPM-2 on DLK-1, and this PHR protein employs ubiquitination and phosphatase-based mechanisms to inhibit DLK-1. This observation is based on immunoprecipitation approaches, followed by mass spectrometry, immunoblot, and immunofluorescence analysis, in which Baker et al. showed that RPM-1 binds to and positively regulates PPM-2. As RPM-1 has previously been shown to be a part of a neuronal complex involving multiple proteins <ref type="bibr" target="#b90">[91,</ref><ref type="bibr" target="#b91">92]</ref>, more precise approaches are lacking to confirm that RPM-1 directly binds to PPM-2. In addition, the small segment of the C. elegans DLK-1 containing Ser-874 is not conserved with mammalian DLK, and no functional orthologue of PPM-2 is known in vertebrates <ref type="bibr">(Yan et al., 2012 [65]</ref>).</p><p>In D. melanogaster, <ref type="bibr" target="#b93">Valakh et al. (2013;</ref><ref type="bibr">2015)</ref> showed that cytoskeletal dysregulation activates Wallenda/DLK <ref type="bibr" target="#b93">[94,</ref><ref type="bibr" target="#b94">95]</ref>. <ref type="bibr" target="#b4">Hayne and DiAntonio (2022)</ref> hypothesized that the disruption of the cytoskeletal structure is mediated by the inhibition of the serine/threonine protein phosphatase 2A (PP2A), which ultimately triggers DLK activation <ref type="bibr" target="#b4">[5]</ref>. In addition to cytoskeletal perturbations, the dysregulation of PP2A function leads to a variety of cell type-specific cellular dysfunctions, including defects in mitotic processes, and cell death <ref type="bibr" target="#b95">[96]</ref>. In mammalian cells, pharmaceutical intervention with okadaic acid, an inhibitor of serine/threonine phosphatases including PP2A, showed an increase in the abundance of phosphorylated DLK <ref type="bibr" target="#b71">[72]</ref>, as well as in DLK activity <ref type="bibr" target="#b82">[83]</ref>. However, these experiments have not definitively shown whether DLK is a direct target of PP2A. <ref type="bibr" target="#b82">Daviau et al. (2009)</ref> also showed that the protein phosphotyrosyl-phosphatase inhibitor vanadate induced an approximately 3.5-fold increase in DLK activation compared to activity without treatment and an approximately 1.5-fold greater effect than the effect of okadaic acid. In contrast to PP2A, the authors state that the effect of vanadate on DLK is not a direct effect on the kinase but is mediated through a Src kinase-dependent pathway, and they showed similar results for induction of the PDGF receptor signaling pathway <ref type="bibr" target="#b46">[47,</ref><ref type="bibr" target="#b82">83]</ref>.</p><p>The calcium/calmodulin-dependent serine/threonine protein phosphatase 2B (calcineurin) has also been implicated in the regulation of DLK activity in several studies <ref type="bibr" target="#b9">[10,</ref><ref type="bibr" target="#b11">12,</ref><ref type="bibr" target="#b71">72,</ref><ref type="bibr" target="#b86">87]</ref>. <ref type="bibr" target="#b71">Mata et al. (1996)</ref> showed in rat aggregating glial cell cultures that the inhibition of calcineurin by its selective inhibitor cyclosporin A (CsA) affected DLK electrophoretic mobility only after membrane depolarization by veratridine and not in unstimulated conditions, highlighting membrane depolarization as a prerequisite for the effect of CsA action on DLK <ref type="bibr" target="#b71">[72]</ref>. Consistent with this, Daviau et al. observed no effect of CsA on DLK activity under unstimulated conditions in COS-7 cells transfected with a vector encoding a wild-type T7-DLK sequence <ref type="bibr" target="#b82">[83]</ref>. Controversially, other studies in insulin-producing beta-cells have observed an effect of CsA on DLK activity: (i) the enhancement of DLK-dependent c-Jun phosphorylation <ref type="bibr" target="#b86">[87]</ref>, (ii) increase in DLK kinase activity by an in vitro assay using casein as a substrate and the induction of beta-cell apoptosis <ref type="bibr" target="#b11">[12]</ref>, (iii) augmented DLK-dependent phosphorylation of the c-Jun N-terminal kinase (JNK), increased phosphorylation and activation of DLK at Ser-302, and increased nuclear translocation of DLK with concomitant increase in beta-cell apoptosis <ref type="bibr" target="#b9">[10]</ref>. Most of these DLK/calcineurin-dependent effects were also observed after calcineurin inhibition by tacrolimus (FK506), another structurally distinct, selective calcineurin inhibitor. It should be noted that <ref type="bibr" target="#b71">Mata et al. (1996)</ref>  <ref type="bibr" target="#b71">[72]</ref> and <ref type="bibr" target="#b82">Daviau et al. (2009)</ref>  <ref type="bibr" target="#b82">[83]</ref> used higher concentrations of CsA (30 µM) and a longer treatment time (4 h) than the other studies (5 or 10 µM for 10 or 30 min). Although there is considerable evidence that DLK activity is partly regulated by the serine/protein phosphatase 2B, it is not known whether DLK and calcineurin interact directly. Duque Escobar et al. (2021) revealed a distinct φLxVP motif (aa 362-365) within DLK for interacting with the calcineurin A and B subunit interface, as already described for the NFAT transcription factor <ref type="bibr" target="#b9">[10,</ref><ref type="bibr" target="#b96">97]</ref>. The authors used several mutations to show that Val-364 prevented protein-protein interactions and exhibited increased DLK activity, measured as the phosphorylation of the downstream JNK, inhibition of CRE-dependent gene transcription, and induction of beta-cell apoptosis <ref type="bibr" target="#b9">[10]</ref>. Furthermore, the activation of DLK by the calcineurin inhibitors might contribute to the pathogenesis of post-transplant diabetes mellitus observed after treatment with these immunosuppressant drugs <ref type="bibr" target="#b97">[98]</ref>.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.3.3.">Palmitoylation of DLK</head><p>The dual leucine zipper kinase is crucial for retrograde signaling after injury in neurons and important in brain development, but the activation of DLK can also lead to apoptosis and neuronal degeneration in different disease models, such as ALS or Alzheimer's disease. Due to the importance of the DLK for cell fate, the activity of DLK, at least in neurons, needs to be highly restricted in temporal and spatial manners and confined to local events. In a search for an explanation on how a bioinformatically predicted soluble protein could travel from distant axonal regions back to the nucleus in a controlled way, Holland et al. found and validated an evolutionary conserved cysteine residue (C127, in human DLK) in the DLK as a site for post-translational modification via palmitoylation (Figure <ref type="figure" target="#fig_9">4</ref>) <ref type="bibr" target="#b81">[82]</ref>.  Palmitoylation is a fast, dynamic post-translational modification that is catalyzed by palmitoyl acyl transferases such as zinc aspartate-histidine-histidine-cysteine (zDHHC) family members and reversed by acyl protein thioesterases. Palmitoylated proteins are tethered to membranous structures like vesicles, the golgi, the plasma membrane, or the outer mitochondrial membrane [99]. <ref type="bibr" target="#b81">Holland et al. (2016)</ref> showed that palmitoylated DLK is targeted to motile trafficking vesicles, allowing it to traffic retrogradely in the event of axonal injury <ref type="bibr" target="#b81">[82]</ref>. In addition, palmitoylation is essential for the interaction of DLK with the scaffold protein JNK-interacting protein-3 (JIP3), resulting in the phosphorylation of DLK's direct and indirect substrates, like MKK4/7, JNK3, and c-Jun, rendering palmitoylation as a novel mechanism for regulating DLK activity <ref type="bibr" target="#b99">[100]</ref>. DLK palmitoylation does not require the phosphorylation or homodimerization of DLK; rather, it brings DLK and its substrates into close proximity <ref type="bibr" target="#b81">[82,</ref><ref type="bibr" target="#b100">101]</ref>. A model proposed that palmitoylation tethers DLK and JNK3 to the same axon vesicle membranes and leads to a forward loop, whereby DLK, through activation of MKK4/7, phosphorylates JNK3, which, in turn, activates DLK, thus perpetuating DLK signaling <ref type="bibr" target="#b99">[100]</ref>. This model implies that JNK contributes to the activation of DLK, which has been shown before in non-neuronal and neuronal cells <ref type="bibr" target="#b10">[11,</ref><ref type="bibr" target="#b56">57,</ref><ref type="bibr" target="#b72">73]</ref>. DLK subcellular localization is also palmitoylation-dependent in non-neuronal cells (HEK293T), suggesting that inhibitors of palmitoylation might inhibit DLK activation <ref type="bibr" target="#b101">[102]</ref>. Although not all MLKs are palmitoylated <ref type="bibr" target="#b99">[100]</ref>, many more proteins besides DLK undergo this post-translational modification; thus, interfering with palmitoylation is expected to be very unselective. In an optic nerve crush (ONC) model, Niu et al. (2020) identified the palmitoyltransferase ZDHHC17 as a DLK palmitoylating enzyme <ref type="bibr">[103]</ref>. Taken together, the palmitoylation of DLK represents a mechanism to bring DLK and its substrates into proximity and direct the subcellular localization of this kinase. Stress signals are reported to increase the palmitoylation of DLK, but it remains unknown how palmitoyl acyl transferases become activated.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.3.4.">Regulation via Protein-Protein Interactions</head><p>DLK protein content and, therefore, activity is regulated via the interaction with diverse proteins. The Regulator of Presynaptic Morphology 1 (RPM-1) in C. elegans and Highwire (Hiw) in D. melanogaster were the first proteins demonstrated to interact with DLK-1 and Wallenda, respectively. Together with the human protein associated with Myc (PAM), these proteins are termed PHR (PAM, Highwire, RPM-1) proteins, which are huge proteins with more than 3700 aa containing diverse enzymatic activities and mainly regulate synapse formation and axon termination <ref type="bibr" target="#b103">[104]</ref>. In C. elegans, D. melanogaster, and the dorsal root ganglia of mammals, RPM-1, Highwire, and PHR, respectively, ubiquitinate DLK-1/Wallenda/DLK, leading to the kinase's proteasomal degradation, thus terminating kinase activity <ref type="bibr" target="#b103">[104]</ref>. However, in mammals, PHR does function independently of DLK in Palmitoylation is a fast, dynamic post-translational modification that is catalyzed by palmitoyl acyl transferases such as zinc aspartate-histidine-histidine-cysteine (zDHHC) family members and reversed by acyl protein thioesterases. Palmitoylated proteins are tethered to membranous structures like vesicles, the golgi, the plasma membrane, or the outer mitochondrial membrane [99]. <ref type="bibr" target="#b81">Holland et al. (2016)</ref> showed that palmitoylated DLK is targeted to motile trafficking vesicles, allowing it to traffic retrogradely in the event of axonal injury <ref type="bibr" target="#b81">[82]</ref>. In addition, palmitoylation is essential for the interaction of DLK with the scaffold protein JNK-interacting protein-3 (JIP3), resulting in the phosphorylation of DLK's direct and indirect substrates, like MKK4/7, JNK3, and c-Jun, rendering palmitoylation as a novel mechanism for regulating DLK activity <ref type="bibr" target="#b99">[100]</ref>. DLK palmitoylation does not require the phosphorylation or homodimerization of DLK; rather, it brings DLK and its substrates into close proximity <ref type="bibr" target="#b81">[82,</ref><ref type="bibr" target="#b100">101]</ref>. A model proposed that palmitoylation tethers DLK and JNK3 to the same axon vesicle membranes and leads to a forward loop, whereby DLK, through activation of MKK4/7, phosphorylates JNK3, which, in turn, activates DLK, thus perpetuating DLK signaling <ref type="bibr" target="#b99">[100]</ref>. This model implies that JNK contributes to the activation of DLK, which has been shown before in non-neuronal and neuronal cells <ref type="bibr" target="#b10">[11,</ref><ref type="bibr" target="#b56">57,</ref><ref type="bibr" target="#b72">73]</ref>. DLK subcellular localization is also palmitoylation-dependent in non-neuronal cells (HEK293T), suggesting that inhibitors of palmitoylation might inhibit DLK activation <ref type="bibr" target="#b101">[102]</ref>. Although not all MLKs are palmitoylated <ref type="bibr" target="#b99">[100]</ref>, many more proteins besides DLK undergo this post-translational modification; thus, interfering with palmitoylation is expected to be very unselective. In an optic nerve crush (ONC) model, Niu et al. (2020) identified the palmitoyltransferase ZDHHC17 as a DLK palmitoylating enzyme <ref type="bibr">[103]</ref>. Taken together, the palmitoylation of DLK represents a mechanism to bring DLK and its substrates into proximity and direct the subcellular localization of this kinase. Stress signals are reported to increase the palmitoylation of DLK, but it remains unknown how palmitoyl acyl transferases become activated.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.3.4.">Regulation via Protein-Protein Interactions</head><p>DLK protein content and, therefore, activity is regulated via the interaction with diverse proteins. The Regulator of Presynaptic Morphology 1 (RPM-1) in C. elegans and Highwire (Hiw) in D. melanogaster were the first proteins demonstrated to interact with DLK-1 and Wallenda, respectively. Together with the human protein associated with Myc (PAM), these proteins are termed PHR (PAM, Highwire, RPM-1) proteins, which are huge proteins with more than 3700 aa containing diverse enzymatic activities and mainly regulate synapse formation and axon termination <ref type="bibr" target="#b103">[104]</ref>. In C. elegans, D. melanogaster, and the dorsal root ganglia of mammals, RPM-1, Highwire, and PHR, respectively, ubiquitinate DLK-1/Wallenda/DLK, leading to the kinase's proteasomal degradation, thus terminating kinase activity <ref type="bibr" target="#b103">[104]</ref>. However, in mammals, PHR does function independently of DLK in some neuronal contexts <ref type="bibr" target="#b103">[104]</ref>. Using primary dorsal root ganglia cells as a model, Huntwork-Rodriguez et al. <ref type="bibr">(2013)</ref> showed that the interaction between DLK and the E3 ubiquitin ligase PHR is regulated via the JNK-induced phosphorylation of DLK: the phosphorylation of DLK on Thr-43 and Ser-533 stabilizes DLK, presumably preventing the interaction with PHR1. Under basal conditions, when DLK is not phosphorylated, its abundance is regulated by a balance between PHR1 and the deubiquitinase ubiquitinspecific peptidase 9, X-linked (USP9X) <ref type="bibr" target="#b72">[73]</ref>. In addition to PHR, the FK506-binding proteinlike (FKBPL) and the FK506-binding protein 8 (FKBP8) were identified as DLK-interacting proteins <ref type="bibr" target="#b80">[81]</ref>. By interacting with the N-terminus of DLK, containing its kinase domain, the N-terminus of FKBPL, containing its peptidyl-prolyl isomerase domain, inhibited DLK activity and reduced its protein stability. Both FKBPL and FKBP8 induced DLK degradation via the lysosomal pathway. Additionally, FKBP8-mediated DLK degradation was prevented when Lys-271 was mutated to Arg, which was shown to function as an ubiquitination and SUMOylation site. Thus, FKBP8 induced DLK lysosomal and proteasomal degradation <ref type="bibr" target="#b80">[81]</ref>.</p><p>Whereas the interactions of DLK with PHR, FKBP8, and FKBPL result in the degradation of the kinase and, thus, in its inactivation, the interaction with the scaffold protein JIP brings DLK and its substrates in proximity, thereby increasing and perpetuating DLK activity <ref type="bibr" target="#b57">[58,</ref><ref type="bibr" target="#b58">59]</ref>. In a thorough mutational analysis, Mooney and Whitmarsh (2004) identified two JIP1-interaction sites within DLK, whereby the mutations of Phe-117, Leu-397, and Asp-398 to alanine severely impaired the DLK-JIP1 interaction and JNK phosphorylation <ref type="bibr" target="#b104">[105]</ref>. The DLK-JIP-JNK interaction is regulated via the phosphorylation of JIP: the phosphorylation of JIP1 on Thr-103 by JNK induces the dissociation of DLK from the scaffold protein, DLK homodimerization, activation, and, ultimately, the phosphorylation of JNK. In murine brain cell lysates, the phosphorylation of JIP1 on tyrosine residues by Src kinases increased the affinity of DLK to JIP1, thereby strengthening this interaction and preventing DLK activation <ref type="bibr" target="#b56">[57,</ref><ref type="bibr" target="#b57">58]</ref>. Of note, palmitoylation contributes to bringing DLK, JIP, and JNK into proximity <ref type="bibr" target="#b99">[100]</ref>. The interaction of DLK with specific JIPs seems to be tissue-dependent and contributes to selective DLK action. In the cerebellum of adult mice, where JIP1 was preferentially expressed, DLK was constitutively active in the absence of injury signals.</p><p>In the murine forebrain, where JIP3 and another scaffold protein of DLK, Plenty of SH (POSH), are expressed, DLK becomes activated only by neuronal injury <ref type="bibr" target="#b2">[3,</ref><ref type="bibr">106]</ref>. Further analysis revealed that in the cerebellum but not in the forebrain after neuronal injury, DLK regulated insulin growth factor 1 signaling. Hence, the regulation of DLK action seems to depend on the interaction with particular scaffold proteins and on the tissue <ref type="bibr" target="#b2">[3]</ref>.</p><p>The heat-shock proteins (HSP) are another group of proteins regulating DLK protein abundance and, therefore, enzymatic activity. The HSP90 acts as a chaperone, which, in contrast to other HSPs, facilitates the maturation, complex assembly, localization, and ligand binding of signal transduction proteins like kinases and nuclear receptors <ref type="bibr" target="#b78">[79,</ref><ref type="bibr" target="#b106">107]</ref>. Using HSP90 and DLK inhibition and co-immunoprecipitation assays, an interaction between DLK and HSP90 was shown to occur in D. melanogaster, embryonic DRG neurons and the HEK cell line, whereby the inhibition or loss of HSP90 (or its fly ortholog Hsp83) reduced DLK protein content <ref type="bibr" target="#b78">[79]</ref>. Hence, the interaction between HSP90 and DLK preserves DLK, possibly by preventing the interaction between DLK and PHR1 leading to DLK proteasomal degradation. In contrast, in the cell line COS7, the interaction of activated DLK with HSP70 results in DLK proteasomal degradation, which was dependent on the HSP70 co-chaperone CHIP (C-terminus of HSP70 interacting protein), an E3 ubiquitin ligase <ref type="bibr" target="#b79">[80]</ref>. Notably, both chaperones, HSP90 and HSP70, can interact with the co-chaperone CHIP and induce the proteasomal degradation of their respective clients <ref type="bibr" target="#b107">[108]</ref>. This suggests that the outcome of the interaction of DLK with HSP chaperones does depend on the expression of the co-chaperone CHIP.</p><p>In addition, a direct interaction between DLK and calcineurin has been demonstrated <ref type="bibr" target="#b9">[10]</ref>.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.3.5.">Regulation of DLK via Its Oligomerization</head><p>The homodimerization of DLK via its leucine zipper has been shown to be essential for DLK activity <ref type="bibr" target="#b55">[56]</ref>. Experiments conducted in different cell lines (NIH3T3, COS-1) indicated that the formation of high-molecular DLK polymers occurred in response to the apoptosis-inducing agent Calphostin C, independent of its ability to inhibit protein kinase C (PKC) <ref type="bibr" target="#b108">[109]</ref><ref type="bibr" target="#b109">[110]</ref><ref type="bibr" target="#b110">[111]</ref>. DLK oligomerization was abolished by the tissue-transglutaminase (tTG) inhibitor monodansylcadaverine, indicating that a tTG-catalyzed protein crosslinking reaction was the underlying cause. A model emerged whereby the Calphostin-C-induced intracellular rise of Ca 2+ stimulates Ca 2+ -dependent tTG2 crosslinking-activity, leading to an increase in the DLK polymers. Oligomerization then increases DLK activity and, hence, activates the JNK-Pathway. After JNK-activation, the apoptosis regulator Bax translocates to mitochondria and induces caspase activation, ultimately leading to apoptosis <ref type="bibr" target="#b108">[109]</ref><ref type="bibr" target="#b109">[110]</ref><ref type="bibr" target="#b110">[111]</ref>. It remains unknown which domains of DLK mediate the oligomerization. Nevertheless, bringing single DLK molecules together, either as homo-or oligomers, leads to increased DLK activity.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.">Conclusions</head><p>DLK protein levels, enzymatic activity, and localization are tightly regulated at different levels and via distinct, possibly tissue-dependent mechanisms. In addition, DLK activity and proteins levels are subject to further fine tuning via interactions with several other proteins and/or via post-translational modifications. Furthermore, transcriptional and post-transcriptional mechanisms contribute to DLK regulation. The regulation of DLK by miRNA or siRNA might be a possible tool to modulate DLK expression in a tissue-selective manner. Further elucidation of these diverse mechanisms will contribute to the identification of drug targets to selectively regulate DLK action. Thus, preventing the interaction with cell-selective scaffold proteins <ref type="bibr" target="#b2">[3]</ref> by small molecule protein interaction inhibitors or interfering with subcellular localization of DLK [9,102] might inhibit DLK action more selectively than ATP-competitive small-molecule inhibitors. In addition, other than that issue, the dual leucine zipper mediates DLK homodimerization required for kinase activity, though not much is known about its impact regulating DLK activity. Do proteins, besides the CREB-regulated transcriptional coactivators (CRTCs), interact with the dimerized leucine zipper of DLK [112] and, possibly, interfere with the kinase's action? Does the dimerization induce a conformational change in DLK, enabling the access to the catalytic domain, thereby regulating DLK at yet another level? The answers to these questions might open an avenue to the cell-or tissue-selective regulation of DLK action.</p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head>Figure 1 .</head><label>1</label><figDesc>Figure 1. Mixed-lineage kinase (MLK) subfamilies. Schematic depiction of the functional domains of different MLK family members (not to scale). MLK (mixed-lineage kinase), DLK (dual leucine zipper kinase), LZK (leucine zipper kinase), ZAK (sterile alpha motif and leucine zipper containing kinase AZK), SH3 (Src homology 3 domain), LZ (Leucine Zipper), CRIB (Cdc42/Rac interactivebinding), and SAM (sterile-α motif). NCBI RefSeq accession numbers (if applicable): MLK1/MAP3K9 (NP_001271159.1, Isoform 2), MLK2/MAP3K10 (NP_002437.2), MLK3/MAP3K11 (NP_002410.1), MLK 4/MAP3K21 (CAC84639.1, Isoform 1/α; NP_115811.2, Isoform 2/β),</figDesc><graphic coords="5,165.14,160.45,389.76,139.44" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><head>Figure 1 .</head><label>1</label><figDesc>Figure 1. Mixed-lineage kinase (MLK) subfamilies. Schematic depiction of the functional domains of different MLK family members (not to scale). MLK (mixed-lineage kinase), DLK (dual leucine zipper kinase), LZK (leucine zipper kinase), ZAK (sterile alpha motif and leucine zipper containing kinase AZK), SH3 (Src homology 3 domain), LZ (Leucine Zipper), CRIB (Cdc42/Rac interactivebinding), and SAM (sterile-α motif). NCBI RefSeq accession numbers (if applicable): MLK1/MAP3K9 (NP_001271159.1, Isoform 2), MLK2/MAP3K10 (NP_002437.2), MLK3/MAP3K11 (NP_002410.1), MLK 4/MAP3K21 (CAC84639.1, Isoform 1/α; NP_115811.2, Isoform 2/β), DLK/MAP3K12 (NP_001180440.1, Isoform 1), LZK/MAP3K13 (NP_004712.1, Isoform 1), and ZAK/MAP3K20 (NP_057737.2, Isoform 1/α; NP_598407.1, Isoform 2/β).</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_2"><head></head><label></label><figDesc>poly(rC) binding protein 2 (PCBP2) gene, both located on the positive strand in opposite directions relative to the DLK gene. The transcripts of the human DLK Isoforms 1 (NM_001193511.2) and 2 (NM_006301.4) differ in a 99 nt stretch that is absent in Isoform 2, resulting in a slightly shorter protein of 859 amino acids (aa) and a calculated molecular weight of https://www.ncbi.nlm.nih.gov/gene/7786, 30 June 2023, 14:33. conserved) (Figure2).</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_3"><head>Figure 2 .</head><label>2</label><figDesc>Figure 2. The human MAP3K12 gene spans 21.871 nucleotides (nt) and is located on the complementary strand of chromosome 12, GRCh38.p14 Primary Assembly. It is flanked by the gene encoding for the TARBP2 subunit of RISC loading complex (TARBP2) and the poly(rC) binding protein 2 (PCBP2) gene, both located on the positive strand in opposite directions relative to the DLK gene. The transcripts of the human DLK Isoforms 1 (NM_001193511.2) and 2 (NM_006301.4) differ in a 99 nt stretch absent in Isoform 2, resulting in a slightly shorter protein of 859 amino acids (aa) and a calculated molecular weight of 93.2 kDa instead of 892 aa and 96.3 kDa. Data were retrieved from NCBI (https://www.ncbi.nlm.nih.gov/gene/7786, 30 June 2023, 14:33). The figure created using Bio-Render.</figDesc><graphic coords="7,166.40,87.66,388.56,175.68" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_4"><head>Figure 2 .</head><label>2</label><figDesc>Figure 2. The human MAP3K12 gene spans 21.871 nucleotides (nt) and is located on the complementary strand of chromosome 12, GRCh38.p14 Primary Assembly. It is flanked by the gene encoding for the TARBP2 subunit of RISC loading complex (TARBP2) and the poly(rC) binding protein 2 (PCBP2) gene, both located on the positive strand in opposite directions relative to the DLK gene. The transcripts of the human DLK Isoforms 1 (NM_001193511.2) and 2 (NM_006301.4) differ in a 99 nt stretch absent in Isoform 2, resulting in a slightly shorter protein of 859 amino acids (aa) and a calculated molecular weight of 93.2 kDa instead of 892 aa and 96.3 kDa. Data were retrieved from NCBI (https://www.ncbi.nlm.nih.gov/gene/7786, 30 June 2023, 14:33). The figure created using BioRender.</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_5"><head>2. 3 .</head><label>3</label><figDesc>Regulation of DLK at the Post-Translational Level 2.3.1. Phosphorylation of DLK</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_6"><head>Figure 3 .</head><label>3</label><figDesc>Figure 3. Examples for regulation of DLK activity. (A) Under basal unstimulated conditions, unphosphorylated DLK protein abundance is regulated by the E3 ubiquitin ligase PHR1 and the deubiquitinase USP9X. (B) Signals activating cAMP and PKA phosphorylate dimerized DLK on Ser-302, leading to the activation of MKK4/7 and JNK. JNK, in turn, phosphorylates DLK on Thr-43 and Ser-535, preventing the interaction with PHR1, thereby stabilizing DLK. Other signals activating MAP4K phosphorylate DLK on Thr-43 and stabilize DLK. (C) Upon an increase in the intracellular calcium concentration, calcineurin interacts with monomeric or dimeric DLK and dephosphorylates the kinase. The inhibition of calcineurin by ROS prevents the dephosphorylation of DLK, whereas the interaction of immunophilin-bound CsA or FK506 displaces DLK from the calcineurin interaction site, and DLK dimerizes and autophosphorylates in trans. For further information, please see the text.</figDesc><graphic coords="8,165.35,259.22,391.44,227.04" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_7"><head>Figure 3 .</head><label>3</label><figDesc>Figure 3. Examples for regulation of DLK activity. (A) Under basal unstimulated conditions, unphosphorylated DLK protein abundance is regulated by the E3 ubiquitin ligase PHR1 and the deubiquitinase USP9X. (B) Signals activating cAMP and PKA phosphorylate dimerized DLK on Ser-302, leading to the activation of MKK4/7 and JNK. JNK, in turn, phosphorylates DLK on Thr-43 and Ser-535, preventing the interaction with PHR1, thereby stabilizing DLK. Other signals activating MAP4K phosphorylate DLK on Thr-43 and stabilize DLK. (C) Upon an increase in the intracellular calcium concentration, calcineurin interacts with monomeric or dimeric DLK and dephosphorylates the kinase. The inhibition of calcineurin by ROS prevents the dephosphorylation of DLK, whereas the interaction of immunophilin-bound CsA or FK506 displaces DLK from the calcineurin interaction site, and DLK dimerizes and autophosphorylates in trans. For further information, please see the text.</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_9"><head>Figure 4 .</head><label>4</label><figDesc>Figure 4. DLK amino acid residues are modulated at the post-translational level. Isoform 1 of human DLK is depicted; T-threonin; C-cystein; K-lysin; S-serin; orange dots-phosphorylation and, possibly, dephosphorylation sites; violet dot-palmitoylation site; blue dot-ubiquitylation and SUMOylation site. KD-kinase domain; AL-activation loop within the kinase domain; LZ-leucine zipper for homodimerization; NLS-bipartite nuclear localization site; NES-nuclear export site; K185-ATP binding site; L-leucine; x-any amino acid; V-valine; P-proline; LxVP-interaction site with calcineurin. For further information, please see the text.</figDesc><graphic coords="11,165.14,181.23,390.00,72.96" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_10"><head>Figure 4 .</head><label>4</label><figDesc>Figure 4. DLK amino acid residues are modulated at the post-translational level. Isoform 1 of human DLK is depicted; T-threonin; C-cystein; K-lysin; S-serin; orange dots-phosphorylation and, possibly, dephosphorylation sites; violet dot-palmitoylation site; blue dot-ubiquitylation and SUMOylation site. KD-kinase domain; AL-activation loop within the kinase domain; LZ-leucine zipper for homodimerization; NLS-bipartite nuclear localization site; NES-nuclear export site; K185-ATP binding site; L-leucine; x-any amino acid; V-valine; P-proline; LxVP-interaction site with calcineurin. For further information, please see the text.</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_0"><head>Table 1 .</head><label>1</label><figDesc>Involvement of DLK in neurological diseases.</figDesc><table><row><cell>Modeled Disease or Disease Mechanism</cell><cell>In Vivo/In Vitro Model (Organism)</cell><cell>Experimental Disease Model</cell><cell>Involvement of DLK</cell><cell>Ref</cell></row><row><cell>Seizure/excitotoxic neurodegeneration</cell><cell>Mouse</cell><cell>Kainic acid</cell><cell>Inducible DLK knock-out reduced neuronal degeneration.</cell><cell>[18]</cell></row><row><cell></cell><cell></cell><cell></cell><cell>Deletion of DLK preserved large</cell><cell></cell></row><row><cell></cell><cell>Mouse</cell><cell>SOD1 G93A mutation</cell><cell>myelinated axons and protected neurons in</cell><cell>[19]</cell></row><row><cell></cell><cell></cell><cell></cell><cell>lumbar spinal cord.</cell><cell></cell></row><row><cell></cell><cell></cell><cell></cell><cell>Dual inhibition of DLK and LZK</cell><cell></cell></row><row><cell></cell><cell>Mouse</cell><cell>SOD1 G93A mutation</cell><cell>suppressed elevation of p-c-Jun and</cell><cell>[20]</cell></row><row><cell>Amyotrophic lateral</cell><cell></cell><cell></cell><cell>neurofilament light (Nf-L).</cell><cell></cell></row><row><cell>sclerosis (ALS)</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell>Mouse Mouse primary neurons Human tissue (postmortem)</cell><cell>SOD1 G93A TDP-43 A315T Trophic factor deprivation ALS patients' lumbar spinal cord</cell><cell></cell><cell></cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_1"><head>Table 2 .</head><label>2</label><figDesc>DLK inhibitors in (pre)clinical studies.</figDesc><table><row><cell>Tested Inhi-bitor</cell><cell>Clinical Trial or Model Organism (In Vivo/In Vitro)</cell><cell>Experimental Disease Model</cell><cell>Modeled Disease or Disease Mechanism</cell><cell>Effect of DLK Inhibition</cell><cell>Ref</cell></row><row><cell></cell><cell>Mouse</cell><cell>Optic nerve crush MPTP toxin) (mitochondrial</cell><cell>Acute nerve injury disease (PD) Parkinson's</cell><cell>Reduced c-Jun neurodegeneration. phosphorylation and</cell><cell>[24]</cell></row><row><cell></cell><cell>D. melanogaster</cell><cell>dFmr1 deletion</cell><cell>Fragile-X-syndrome (FXS)</cell><cell>Suppressed defects in behavior. neuronal development and</cell><cell>[29]</cell></row><row><cell></cell><cell>Mouse</cell><cell>Sciatic nerve transection</cell><cell>Nerve injury/ neuropathic pain</cell><cell>Reduced mechanical allodynia.</cell><cell>[30]</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell>Reduced pain and c-Jun</cell><cell></cell></row><row><cell></cell><cell>Mouse Mouse embryonal DRG explant culture</cell><cell>Cyclophosphamide treatment (p. o.)</cell><cell>Cyclophosphamide-induced cystitis, and bladder pathology inflammation, pain,</cell><cell>phosphorylation in DRG, suppressed activation in the spinal cord cells, and neuronal histamine-release from mast</cell><cell>[31]</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell>and bladder pathology.</cell><cell></cell></row><row><cell>GNE-3511</cell><cell>Mouse embryonal DRG explant culture</cell><cell>Vincristine Axotomy NGF withdrawal Axotomy/forskolin</cell><cell>Wallerian axon degeneration</cell><cell>Delayed and reduced phosphorylation. neurodegeneration. Reduced c-Jun-</cell><cell>[32-36]</cell></row><row><cell></cell><cell>Mouse sympathetic neurons (with latent HSV infection)</cell><cell>Forskolin, IL-1beta and tetrodotoxin Forskolin + by LY204002 PI3K inhibition heat shock</cell><cell>HSV reactivation via neuronal by stress HSV reactivation hyperexcitation</cell><cell>Prevented HSV reactivation.</cell><cell>[37-39]</cell></row><row><cell></cell><cell>Mouse cortical and hippocampal neurons</cell><cell>Overexpression of human Tau</cell><cell>Alzheimer's disease (AD)</cell><cell>Prevented phosphory-lation reduced cytotoxicity. of JNK + c-Jun and</cell><cell>[6]</cell></row><row><cell></cell><cell></cell><cell>Deletion of Myelin</cell><cell></cell><cell>Blocked</cell><cell></cell></row><row><cell></cell><cell>Mouse</cell><cell>Regulatory Factor (Myrf ) (model of</cell><cell>Multiple sclerosis (MS)</cell><cell>c-Jun-phosphorylation and apoptosis of chronically</cell><cell>[40]</cell></row><row><cell></cell><cell></cell><cell>demyelination)</cell><cell></cell><cell>demyelinated neurons.</cell><cell></cell></row><row><cell></cell><cell>Mouse</cell><cell>SOD1 G93A mutation</cell><cell>Amyotrophic lateral sclerosis (ALS)</cell><cell>Reduced p-c-Jun.</cell><cell>[1]</cell></row><row><cell>GNE-8505</cell><cell>CMT2 patient-derived iPSC motor neurons</cell><cell>Patient-derived cells in vitro</cell><cell>Charcot-Marie-Type 2 (CMT2) Tooth neuropathy</cell><cell>Reduced p-c-Jun and dysfunction. restored mitochondrial</cell><cell>[41]</cell></row><row><cell>IACS-52825</cell><cell>Mouse</cell><cell>Cisplatin treatment (i.p.)</cell><cell>Chemotherapy-induced peripheral neuropathy (CIPN)</cell><cell>Reversed mechanical allodynia.</cell><cell>[42]</cell></row><row><cell></cell><cell></cell><cell></cell><cell>Chemotherapy-</cell><cell>Prevented mechanical</cell><cell></cell></row><row><cell></cell><cell></cell><cell></cell><cell>induced peripheral</cell><cell>allodynia, loss of</cell><cell></cell></row><row><cell>IACS-8287</cell><cell>Mouse</cell><cell>Cisplatin treatment (i.p.)</cell><cell>neuropathy (CIPN) Chemotherapy-</cell><cell>intra-epidermal nerve fibers, cognitive deficits, and</cell><cell>[43]</cell></row><row><cell></cell><cell></cell><cell></cell><cell>induced cognitive</cell><cell>impairments of</cell><cell></cell></row><row><cell></cell><cell></cell><cell></cell><cell>impairment (CICI)</cell><cell>brain connectivity.</cell><cell></cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_2"><head>Table 2 .</head><label>2</label><figDesc>Cont.    </figDesc><table><row><cell>Tested Inhi-bitor</cell><cell>Clinical Trial or Model Organism (In Vivo/In Vitro)</cell><cell>Experimental Disease Model</cell><cell>Modeled Disease or Disease Mechanism</cell><cell>Effect of DLK Inhibition</cell><cell>Ref</cell></row><row><cell>GDC-0134</cell><cell>Human (Phase I clinical trial)</cell><cell>ALS patients</cell><cell>Amyotrophic lateral sclerosis (ALS)</cell><cell>Terminated due to adverse effects.</cell><cell>[4]</cell></row><row><cell>DN-1289</cell><cell>Mouse</cell><cell>Optic nerve crush SOD1 G93A mutation</cell><cell>Acute nerve injury Amyotrophic lateral sclerosis (ALS)</cell><cell>Suppressed elevation of p-c-Jun.</cell><cell>[20]</cell></row><row><cell></cell><cell>Human ESC-derived RGCs</cell><cell>Colchicine 1 µM</cell><cell>Axonal injury</cell><cell>Increased dose-dependent survival.</cell><cell>[44]</cell></row><row><cell>Sunitinib</cell><cell>Mouse</cell><cell>Impact acceleration (model of TBI)</cell><cell>Traumatic brain injury (TBI)</cell><cell>Increased RGC survival.</cell><cell>[25]</cell></row><row><cell></cell><cell>Mouse Rat</cell><cell>Optic nerve crush</cell><cell>Glaucoma</cell><cell>Administration by eye drop improved RCG survival.</cell><cell>[45]</cell></row><row><cell></cell><cell></cell><cell>Laser-induced</cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell>Rat</cell><cell>ocular</cell><cell>Glaucoma,</cell><cell>Increased survival of RGCs</cell><cell></cell></row><row><cell></cell><cell>Mouse primary</cell><cell>hypertension</cell><cell>traumatic optic</cell><cell>and reduced axon loss.</cell><cell>[7]</cell></row><row><cell></cell><cell>RGCs</cell><cell>Optic nerve</cell><cell>neuropathies</cell><cell>Increased survival of RGCs</cell><cell></cell></row><row><cell></cell><cell></cell><cell>transection</cell><cell></cell><cell></cell><cell></cell></row><row><cell>Tozasertib</cell><cell>Rat</cell><cell>Endovascular perforation</cell><cell>Brain injury after SAH</cell><cell>Reduced apoptosis of neurons.</cell><cell>[27]</cell></row><row><cell></cell><cell>Human ESC-derived RGCs</cell><cell>Colchicine 1 µM</cell><cell>Axonal injury</cell><cell>Increased dose-dependent survival.</cell><cell></cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_3"><head>Table 3 .</head><label>3</label><figDesc>MAP3K12 Isoforms in different model organisms.</figDesc><table><row><cell>Model Organism</cell><cell>Protein</cell><cell>Accession Number</cell><cell>Isoforms</cell><cell>Length</cell></row><row><cell>Homo sapiens</cell><cell cols="2">MAP3K12, ZPK NP_001180440.1</cell><cell>Isoform 1</cell><cell>892 aa</cell></row><row><cell>Homo sapiens</cell><cell cols="2">MAP3K12, ZPK NP_006292.3</cell><cell>Isoform 2</cell><cell>859 aa</cell></row><row><cell>Mus musculus</cell><cell cols="2">MAP3K12, DLK NP_001157115.1</cell><cell cols="2">(not described) 888 aa</cell></row><row><cell>Rattus norvegicus</cell><cell cols="2">MAP3K12, MUK NP_037187.1</cell><cell cols="2">(not described) 888 aa</cell></row><row><cell>Mesocricetus auratus</cell><cell cols="2">MAP3K12, DLK XP_040609646.1</cell><cell>Isoform X1</cell><cell>920 aa</cell></row><row><cell>Mesocricetus auratus</cell><cell cols="2">MAP3K12, DLK XP_012966775.1</cell><cell>Isoform X2</cell><cell>862 aa</cell></row><row><cell>Mesocricetus auratus</cell><cell cols="2">MAP3K12, DLK XP_005067383.1</cell><cell>Isoform X3</cell><cell>892 aa</cell></row><row><cell cols="2">Caenorhabditis elegans DLK-1</cell><cell>NP_001021443.1</cell><cell>long</cell><cell>928 aa</cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_4"><head>Table 3 .</head><label>3</label><figDesc>MAP3K12 Isoforms in different model organisms.</figDesc><table><row><cell>Model Organism</cell><cell>Protein</cell><cell>Accession Number</cell><cell>Isoforms</cell><cell>Length</cell></row><row><cell>Homo sapiens</cell><cell>MAP3K12, ZPK</cell><cell>NP_001180440.1</cell><cell>Isoform 1</cell><cell>892 aa</cell></row><row><cell>Homo sapiens</cell><cell>MAP3K12, ZPK</cell><cell>NP_006292.3</cell><cell>Isoform 2</cell><cell>859 aa</cell></row><row><cell>Mus musculus</cell><cell>MAP3K12, DLK</cell><cell>NP_001157115.1</cell><cell>(not described)</cell><cell>888 aa</cell></row><row><cell>Rattus norvegicus</cell><cell>MAP3K12, MUK</cell><cell>NP_037187.1</cell><cell>(not described)</cell><cell>888 aa</cell></row><row><cell>Mesocricetus auratus</cell><cell>MAP3K12, DLK</cell><cell>XP_040609646.1</cell><cell>Isoform X1</cell><cell>920 aa</cell></row><row><cell>Mesocricetus auratus</cell><cell>MAP3K12, DLK</cell><cell>XP_012966775.1</cell><cell>Isoform X2</cell><cell>862 aa</cell></row><row><cell>Mesocricetus auratus</cell><cell>MAP3K12, DLK</cell><cell>XP_005067383.1</cell><cell>Isoform X3</cell><cell>892 aa</cell></row><row><cell>Caenorhabditis elegans</cell><cell>DLK-1</cell><cell>NP_001021443.1</cell><cell>long</cell><cell>928 aa</cell></row><row><cell>Caenorhabditis elegans</cell><cell>DLK-1</cell><cell>NP_001021445.1</cell><cell>short</cell><cell>577 aa</cell></row><row><cell>Drosophila melanogaster</cell><cell>Wallenda, WND</cell><cell>NP_649137.3</cell><cell>Isoform (A)</cell><cell>977 aa</cell></row><row><cell>Drosophila melanogaster</cell><cell>Wallenda, WND</cell><cell>NP_788540.1</cell><cell>Isoform (B)</cell><cell>977 aa</cell></row><row><cell>Drosophila melanogaster</cell><cell>Wallenda, WND</cell><cell>NP_788541.1</cell><cell>Isoform (C)</cell><cell>977 aa</cell></row><row><cell>Drosophila melanogaster</cell><cell>Wallenda, WND</cell><cell>NP_001189132.1</cell><cell>Isoform (D)</cell><cell>950 aa</cell></row></table></figure>
		</body>
		<back>

			<div type="availability">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Data Availability Statement: Not applicable.</head><p>Acknowledgments: We thank WormBase WS290.</p></div>
			</div>

			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Conflicts of Interest:</head><p>The authors declare no conflicts of interest.</p><p>Cells 2024, 13, 333</p></div>			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main">Loss of dual leucine zipper kinase signaling is protective in animal models of neurodegenerative disease</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">E</forename><surname>Le Pichon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">J</forename><surname>Meilandt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Dominguez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Solanoy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Lin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Ngu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Gogineni</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Sengupta Ghosh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Jiang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S.-H</forename><surname>Lee</surname></persName>
		</author>
		<idno type="DOI">10.1126/scitranslmed.aag0394</idno>
	</analytic>
	<monogr>
		<title level="j">Sci. Transl. Med</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
	<note>eaag0394. [CrossRef</note>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">ApoE2, ApoE3, and ApoE4 Differentially Stimulate APP Transcription and Aβ Secretion</title>
		<author>
			<persName><forename type="first">Y.-W</forename><forename type="middle">A</forename><surname>Huang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Zhou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Wernig</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">C</forename><surname>Südhof</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.cell.2016.12.044</idno>
	</analytic>
	<monogr>
		<title level="j">Cell</title>
		<imprint>
			<biblScope unit="volume">168</biblScope>
			<biblScope unit="page" from="427" to="441" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
	<note>e21. [CrossRef</note>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">Dual Leucine Zipper Kinase Is Constitutively Active in the Adult Mouse Brain and Has Both Stress-Induced and Homeostatic Functions</title>
		<author>
			<persName><forename type="first">S</forename><surname>Goodwani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Fernandez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">J</forename><surname>Acton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Buggia-Prevot</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">L</forename><surname>Mcreynolds</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Ma</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">H</forename><surname>Hu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">E</forename><surname>Hamby</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Jiang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Le</surname></persName>
		</author>
		<idno type="DOI">10.3390/ijms21144849</idno>
	</analytic>
	<monogr>
		<title level="j">Int. J. Mol. Sci</title>
		<imprint>
			<biblScope unit="volume">21</biblScope>
			<biblScope unit="page">4849</biblScope>
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">A Phase 1 study of GDC-0134, a dual leucine zipper kinase inhibitor, in ALS</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">S</forename><surname>Katz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">D</forename><surname>Rothstein</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">E</forename><surname>Cudkowicz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Genge</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Oskarsson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">B</forename><surname>Hains</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Galanter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">L</forename><surname>Burgess</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Cho</surname></persName>
		</author>
		<idno type="DOI">10.1002/acn3.51491</idno>
	</analytic>
	<monogr>
		<title level="j">Ann. Clin. Transl. Neurol</title>
		<imprint>
			<biblScope unit="volume">2022</biblScope>
			<biblScope unit="page" from="50" to="66" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">Protein phosphatase 2A restrains DLK signaling to promote proper Drosophila synaptic development and mammalian cortical neuron survival</title>
		<author>
			<persName><forename type="first">M</forename><surname>Hayne</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Diantonio</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.nbd.2021.105586</idno>
	</analytic>
	<monogr>
		<title level="j">Neurobiol. Dis</title>
		<imprint>
			<biblScope unit="volume">163</biblScope>
			<date type="published" when="2022">2022. 105586</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">DLK-MAPK Signaling Coupled with DNA Damage Promotes Intrinsic Neurotoxicity Associated with Non-Mutated Tau</title>
		<author>
			<persName><forename type="first">S</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">R</forename><surname>Roy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Watkins</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Cao</surname></persName>
		</author>
		<idno type="DOI">10.1007/s12035-023-03720-1</idno>
	</analytic>
	<monogr>
		<title level="j">Mol. Neurobiol</title>
		<imprint>
			<date type="published" when="2023">2023</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">Functional genomic screening identifies dual leucine zipper kinase as a key mediator of retinal ganglion cell death</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">S</forename><surname>Welsbie</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Yang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Ge</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">L</forename><surname>Mitchell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Zhou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">E</forename><surname>Martin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">A</forename><surname>Berlinicke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Hackler</surname></persName>
		</author>
		<author>
			<persName><surname>Jr</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Fuller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Fu</surname></persName>
		</author>
		<idno type="DOI">10.1073/pnas.1211284110</idno>
	</analytic>
	<monogr>
		<title level="j">Proc. Natl. Acad. Sci</title>
		<imprint>
			<biblScope unit="volume">110</biblScope>
			<biblScope unit="page" from="4045" to="4050" />
			<date type="published" when="2013">2013</date>
			<pubPlace>USA</pubPlace>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">Regulation of Beta-Cell Function and Mass by the Dual Leucine Zipper Kinase</title>
		<author>
			<persName><forename type="first">E</forename><surname>Oetjen</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Arch. Der Pharm</title>
		<imprint>
			<biblScope unit="volume">349</biblScope>
			<biblScope unit="page" from="410" to="413" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">Distinct functions of the dual leucine zipper kinase depending on its subcellular localization</title>
		<author>
			<persName><forename type="first">M</forename><surname>Wallbach</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Duque Escobar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Babaeikelishomi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M.-J</forename><surname>Stahnke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Blume</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Schröder</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Kruegel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Maedler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Kluth</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">H</forename><surname>Kehlenbach</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.cellsig.2016.01.002</idno>
	</analytic>
	<monogr>
		<title level="j">Cell. Signal</title>
		<imprint>
			<biblScope unit="volume">28</biblScope>
			<biblScope unit="page" from="272" to="283" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main">Regulation of dual leucine zipper kinase activity through its interaction with calcineurin</title>
		<author>
			<persName><forename type="first">Duque</forename><surname>Escobar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Kutschenko</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Schröder</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Blume</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Köster</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K.-A</forename><surname>Painer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Lemcke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Maison</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Oetjen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename></persName>
		</author>
		<idno type="DOI">10.1016/j.cellsig.2021.109953</idno>
	</analytic>
	<monogr>
		<title level="j">Cell. Signal</title>
		<imprint>
			<biblScope unit="volume">82</biblScope>
			<date type="published" when="2021">2021. 109953</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main">TNFα-induced DLK activation contributes to apoptosis in the beta-cell line HIT</title>
		<author>
			<persName><forename type="first">S</forename><surname>Börchers</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Babaei</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Klimpel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Duque Escobar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Schröder</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Blume</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">N H</forename><surname>Malik</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Oetjen</surname></persName>
		</author>
		<idno type="DOI">10.1007/s00210-017-1385-0</idno>
	</analytic>
	<monogr>
		<title level="j">Naunyn-Schmiedeberg&apos;s Arch. Pharmacol</title>
		<imprint>
			<biblScope unit="volume">390</biblScope>
			<biblScope unit="page" from="813" to="825" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main">Activation of the Dual-Leucine-Zipper-Bearing Kinase and Induction of β-Cell Apoptosis by the Immunosuppressive Drug Cyclosporin A</title>
		<author>
			<persName><forename type="first">S</forename><surname>Plaumann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Blume</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Börchers</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">J</forename><surname>Steinfelder</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Knepel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Oetjen</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Mol. Pharmacol</title>
		<imprint>
			<biblScope unit="volume">73</biblScope>
			<biblScope unit="page" from="652" to="659" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main">Inhibition of human insulin gene transcription and MafA transcriptional activity by the dual leucine zipper kinase</title>
		<author>
			<persName><forename type="first">M.-J</forename><surname>Stahnke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Dickel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Schröder</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Kaiser</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Blume</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Stein</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Pouponnot</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Oetjen</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.cellsig.2014.04.006</idno>
	</analytic>
	<monogr>
		<title level="j">Cell. Signal</title>
		<imprint>
			<biblScope unit="volume">26</biblScope>
			<biblScope unit="page" from="1792" to="1799" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main">Bioinformatics Analysis of Next Generation Sequencing Data Identifies Molecular Biomarkers Associated With Type 2 Diabetes Mellitus</title>
		<author>
			<persName><forename type="first">V</forename><surname>Alur</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Raju</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Vastrad</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Vastrad</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Kavatagimath</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Kotturshetti</surname></persName>
		</author>
		<idno type="DOI">10.1177/11795514231155635</idno>
	</analytic>
	<monogr>
		<title level="j">Clin. Med. Insights Endocrinol. Diabetes</title>
		<imprint>
			<biblScope unit="volume">16</biblScope>
			<date type="published" when="2023">2023. 11795514231155635</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main">Genome-wide association study identifies 112 new loci for body mass index in the Japanese population</title>
		<author>
			<persName><forename type="first">M</forename><surname>Akiyama</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Okada</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Kanai</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Takahashi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Momozawa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Ikeda</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Iwata</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Ikegawa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Hirata</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Matsuda</surname></persName>
		</author>
		<idno type="DOI">10.1038/ng.3951</idno>
	</analytic>
	<monogr>
		<title level="j">Nat. Genet</title>
		<imprint>
			<biblScope unit="volume">49</biblScope>
			<biblScope unit="page" from="1458" to="1467" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main">The Map3k12 (Dlk)/JNK3 signaling pathway is required for pancreatic beta-cell proliferation during postnatal development</title>
		<author>
			<persName><forename type="first">M</forename><surname>Tenenbaum</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Plaisance</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Boutry</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Pawlowski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Jacovetti</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Sanchez-Parra</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Ezanno</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Bourry</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Beeler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Pasquetti</surname></persName>
		</author>
		<idno type="DOI">10.1007/s00018-020-03499-7</idno>
	</analytic>
	<monogr>
		<title level="j">Cell. Mol. Life Sci</title>
		<imprint>
			<biblScope unit="volume">78</biblScope>
			<biblScope unit="page" from="287" to="298" />
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main">The c-Jun N-Terminal Kinase Activator Dual Leucine Zipper Kinase Regulates Axon Growth and Neuronal Migration in the Developing Cerebral Cortex</title>
		<author>
			<persName><forename type="first">S</forename><surname>Hirai</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>-I.; Feng Cui</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Miyata</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Ogawa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Kiyonari</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Suda</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Aizawa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Banba</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Ohno</surname></persName>
		</author>
		<idno type="DOI">10.1523/JNEUROSCI.2272-06.2006</idno>
	</analytic>
	<monogr>
		<title level="j">J. Neurosci</title>
		<imprint>
			<biblScope unit="volume">26</biblScope>
			<biblScope unit="page" from="11992" to="12002" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main">Dual leucine zipper kinase is required for excitotoxicity-induced neuronal degeneration</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">D</forename><surname>Pozniak</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Sengupta Ghosh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Gogineni</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">E</forename><surname>Hanson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">H</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">L</forename><surname>Larson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Solanoy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Bustos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Ngu</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Exp. Med</title>
		<imprint>
			<biblScope unit="volume">210</biblScope>
			<biblScope unit="page" from="2553" to="2567" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main">Promoting regeneration while blocking cell death preserves motor neuron function in a model of ALS</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">J</forename><surname>Wlaschin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Donahue</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Gluski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">F</forename><surname>Osborne</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">M</forename><surname>Ramos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Silberberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">E</forename><surname>Le Pichon</surname></persName>
		</author>
		<idno type="DOI">10.1093/brain/awac415</idno>
	</analytic>
	<monogr>
		<title level="j">Brain</title>
		<imprint>
			<biblScope unit="volume">146</biblScope>
			<date type="published" when="2016">2023. 2016-2028</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main">Discovery of Potent and Selective Dual Leucine Zipper Kinase/Leucine Zipper-Bearing Kinase Inhibitors with Neuroprotective Properties in In Vitro and In Vivo Models of Amyotrophic Lateral Sclerosis</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">A</forename><surname>Craig</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">M</forename><surname>Ii; Fox</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Hu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">W</forename><surname>Lexa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Osipov</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">P</forename><surname>Thottumkara</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Larhammar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Miyamoto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Rana</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">A</forename><surname>Kane</surname></persName>
		</author>
		<idno type="DOI">10.1021/acs.jmedchem.2c01056</idno>
	</analytic>
	<monogr>
		<title level="j">J. Med. Chem</title>
		<imprint>
			<biblScope unit="volume">65</biblScope>
			<biblScope unit="page" from="16290" to="16312" />
			<date type="published" when="2022">2022</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b20">
	<monogr>
		<title level="m" type="main">Modeling Alzheimer&apos;s disease in primary neurons reveals DNA damage response coupled with MAPK-DLK signaling in wild-type tau-induced neurodegeneration</title>
		<author>
			<persName><forename type="first">S</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">R</forename><surname>Roy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Watkins</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Cao</surname></persName>
		</author>
		<idno type="DOI">10.21203/rs.3.rs-2617457/v1</idno>
		<imprint/>
	</monogr>
	<note>Res. Sq. 2023, ahead of print</note>
</biblStruct>

<biblStruct xml:id="b21">
	<monogr>
		<title level="m" type="main">MiR-191-5p alleviates microglial cell injury by targeting Map3k12 (mitogen-activated protein kinase kinase kinase 12) to inhibit the MAPK (mitogen-activated protein kinase) signaling pathway in Alzheimer&apos;s disease</title>
		<author>
			<persName><forename type="first">W</forename><surname>Wan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Pan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Hu</surname></persName>
		</author>
		<idno type="DOI">10.1080/21655979.2021.2008638</idno>
		<imprint>
			<date type="published" when="2021">2021</date>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="page" from="12678" to="12690" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main">Antiapoptotic and trophic effects of dominant-negative forms of dual leucine zipper kinase in dopamine neurons of the substantia nigra in vivo</title>
		<author>
			<persName><forename type="first">X</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Rzhetskaya</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Kareva</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Bland</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>During</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">W</forename><surname>Tank</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Kholodilov</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">E</forename><surname>Burke</surname></persName>
		</author>
		<idno type="DOI">10.1523/JNEUROSCI.2132-07.2008</idno>
	</analytic>
	<monogr>
		<title level="j">J. Neurosci</title>
		<imprint>
			<biblScope unit="volume">28</biblScope>
			<biblScope unit="page" from="672" to="680" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main">Discovery of dual leucine zipper kinase (DLK, MAP3K12) inhibitors with activity in neurodegeneration models</title>
		<author>
			<persName><forename type="first">S</forename><surname>Patel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Cohen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">J</forename><surname>Dean</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>De La Torre</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Deshmukh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">A</forename><surname>Estrada</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">S</forename><surname>Ghosh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Gibbons</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Gustafson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">P</forename><surname>Huestis</surname></persName>
		</author>
		<idno type="DOI">10.1021/jm5013984</idno>
	</analytic>
	<monogr>
		<title level="j">J. Med. Chem</title>
		<imprint>
			<biblScope unit="volume">58</biblScope>
			<biblScope unit="page" from="401" to="418" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main">Targeted disruption of dual leucine zipper kinase and leucine zipper kinase promotes neuronal survival in a model of diffuse traumatic brain injury</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">S</forename><surname>Welsbie</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">K</forename><surname>Ziogas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Xu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B.-J</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Ge</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">K</forename><surname>Patel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Ryu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Lehar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">S</forename><surname>Alexandris</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Stewart</surname></persName>
		</author>
		<idno type="DOI">10.1186/s13024-019-0345-1</idno>
	</analytic>
	<monogr>
		<title level="j">Mol. Neurodegener</title>
		<imprint>
			<biblScope unit="volume">14</biblScope>
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main">DLK silencing attenuated neuron apoptosis through JIP3/MA2K7/JNK pathway in early brain injury after SAH in rats</title>
		<author>
			<persName><forename type="first">C</forename><surname>Yin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Huang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>-F.; Sun</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>-C.; Guo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">H</forename><surname>Zhang</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.nbd.2017.04.006</idno>
	</analytic>
	<monogr>
		<title level="j">Neurobiol. Dis</title>
		<imprint>
			<biblScope unit="volume">103</biblScope>
			<biblScope unit="page" from="133" to="143" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main">Tozasertib attenuates neuronal apoptosis via DLK/JIP3/MA2K7/JNK pathway in early brain injury after SAH in rats</title>
		<author>
			<persName><forename type="first">C</forename><surname>Yin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Huang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>-F.; Sun</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>-C.; Guo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">H</forename><surname>Zhang</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.neuropharm.2016.04.013</idno>
	</analytic>
	<monogr>
		<title level="j">Neuropharmacology</title>
		<imprint>
			<biblScope unit="volume">108</biblScope>
			<biblScope unit="page" from="316" to="323" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main">CCR5 Is a Therapeutic Target for Recovery after Stroke and Traumatic Brain Injury</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">T</forename><surname>Joy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Ben Assayag</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Shabashov-Stone</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Liraz-Zaltsman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Mazzitelli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Arenas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Abduljawad</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Kliper</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">D</forename><surname>Korczyn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">S</forename><surname>Thareja</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.cell.2019.01.044</idno>
	</analytic>
	<monogr>
		<title level="j">Cell</title>
		<imprint>
			<biblScope unit="volume">176</biblScope>
			<biblScope unit="page" from="1143" to="1157" />
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main">Wnd/DLK Is a Critical Target of FMRP Responsible for Neurodevelopmental and Behavior Defects in the Drosophila Model of Fragile X Syndrome</title>
		<author>
			<persName><forename type="first">A</forename><surname>Russo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Diantonio</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.celrep.2019.08.001</idno>
	</analytic>
	<monogr>
		<title level="j">Cell Rep</title>
		<imprint>
			<biblScope unit="volume">28</biblScope>
			<biblScope unit="page" from="2581" to="2593" />
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
	<note>e5. [CrossRef</note>
</biblStruct>

<biblStruct xml:id="b29">
	<monogr>
		<title level="m" type="main">Dual leucine zipper kinase is required for mechanical allodynia and microgliosis after nerve injury</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">J</forename><surname>Wlaschin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Gluski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Nguyen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Silberberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">H</forename><surname>Thompson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">T</forename><surname>Chesler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">E</forename><surname>Le Pichon</surname></persName>
		</author>
		<idno type="DOI">10.7554/eLife.33910</idno>
		<imprint>
			<date type="published" when="2018">2018</date>
			<biblScope unit="volume">7</biblScope>
		</imprint>
	</monogr>
	<note>e33910. [CrossRef</note>
</biblStruct>

<biblStruct xml:id="b30">
	<analytic>
		<title level="a" type="main">Neuronal Dual Leucine Zipper Kinase Mediates Inflammatory and Nociceptive Responses in Cyclophosphamide-Induced Cystitis</title>
		<author>
			<persName><forename type="first">C</forename><surname>Jiang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Fang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Lv</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Gu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Lv</surname></persName>
		</author>
		<idno type="DOI">10.1159/000514545</idno>
	</analytic>
	<monogr>
		<title level="j">J. Innate Immun</title>
		<imprint>
			<biblScope unit="volume">13</biblScope>
			<biblScope unit="page" from="259" to="268" />
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b31">
	<analytic>
		<title level="a" type="main">Vincristine and bortezomib use distinct upstream mechanisms to activate a common SARM1-dependent axon degeneration program</title>
		<author>
			<persName><forename type="first">S</forename><surname>Geisler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">A</forename><surname>Doan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">C</forename><surname>Cheng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Cetinkaya-Fisgin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">X</forename><surname>Huang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Höke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Milbrandt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Diantonio</surname></persName>
		</author>
		<idno type="DOI">10.1172/jci.insight.129920</idno>
	</analytic>
	<monogr>
		<title level="j">JCI Insight</title>
		<imprint>
			<date type="published" when="2019">2019, 4, e129920</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b32">
	<analytic>
		<title level="a" type="main">The Ste20 Family Kinases MAP4K4, MINK1, and TNIK Converge to Regulate Stress-Induced JNK Signaling in Neurons</title>
		<author>
			<persName><forename type="first">M</forename><surname>Larhammar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Huntwork-Rodriguez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Rudhard</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Sengupta-Ghosh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">W</forename><surname>Lewcock</surname></persName>
		</author>
		<idno type="DOI">10.1523/JNEUROSCI.0905-17.2017</idno>
	</analytic>
	<monogr>
		<title level="j">J. Neurosci</title>
		<imprint>
			<biblScope unit="volume">37</biblScope>
			<biblScope unit="page" from="11074" to="11084" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b33">
	<monogr>
		<title level="m" type="main">Dual leucine zipper kinase-dependent PERK activation contributes to neuronal degeneration following insult</title>
		<author>
			<persName><forename type="first">M</forename><surname>Larhammar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Huntwork-Rodriguez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Jiang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Solanoy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Sengupta Ghosh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">S</forename><surname>Kaminker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Huang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Eastham-Anderson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Siu</surname></persName>
		</author>
		<idno type="DOI">10.7554/eLife.20725</idno>
		<imprint>
			<date type="published" when="2017">2017. 20725</date>
			<biblScope unit="volume">6</biblScope>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b34">
	<analytic>
		<title level="a" type="main">DLK Activation Synergizes with Mitochondrial Dysfunction to Downregulate Axon Survival Factors and Promote SARM1-Dependent Axon Degeneration</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">W</forename><surname>Summers</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Frey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">J</forename><surname>Walker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Milbrandt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Diantonio</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Mol. Neurobiol</title>
		<imprint>
			<biblScope unit="volume">57</biblScope>
			<biblScope unit="page" from="1146" to="1158" />
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b35">
	<analytic>
		<title level="a" type="main">Protective effects of NAMPT or MAPK inhibitors and NaR on Wallerian degeneration of mammalian axons</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">S</forename><surname>Alexandris</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Ryu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Rajbhandari</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Harlan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Mckenney</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Aja</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Graham</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Venkatesan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">E</forename><surname>Koliatsos</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.nbd.2022.105808</idno>
	</analytic>
	<monogr>
		<title level="j">Neurobiol. Dis</title>
		<imprint>
			<biblScope unit="volume">171</biblScope>
			<date type="published" when="2022">2022. 105808</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b36">
	<monogr>
		<title level="m" type="main">Neuronal hyperexcitability is a DLK-dependent trigger of herpes simplex virus reactivation that can be induced by IL-1</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">R</forename><surname>Cuddy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">R</forename><surname>Schinlever</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Dochnal</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">V</forename><surname>Seegren</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Suzich</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Kundu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">K</forename><surname>Downs</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Farah</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">N</forename><surname>Desai</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Boutell</surname></persName>
		</author>
		<idno type="DOI">10.7554/eLife.58037</idno>
		<imprint/>
	</monogr>
	<note>. eLife 2020, 9, e58037. [CrossRef</note>
</biblStruct>

<biblStruct xml:id="b37">
	<analytic>
		<title level="a" type="main">DLK-Dependent Biphasic Reactivation of Herpes Simplex Virus Latency Established in the Absence of Antivirals</title>
		<author>
			<persName><forename type="first">S</forename><surname>Dochnal</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">Y</forename><surname>Merchant</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">R</forename><surname>Schinlever</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Babnis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">P</forename><surname>Depledge</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">C</forename><surname>Wilson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">R</forename><surname>Cliffe</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Virol</title>
		<imprint>
			<biblScope unit="volume">96</biblScope>
			<biblScope unit="page" from="508" to="e522" />
			<date type="published" when="2022">2022</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b38">
	<analytic>
		<title level="a" type="main">Ex Vivo Herpes Simplex Virus Reactivation Involves a Dual Leucine Zipper Kinase-Dependent Wave of Lytic Gene Expression That Is Independent of Histone Demethylase Activity and Viral Genome Synthesis</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">L</forename><surname>Whitford</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">A</forename><surname>Clinton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">B L</forename><surname>Kennedy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">A</forename><surname>Dochnal</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">B</forename><surname>Suzich</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">R</forename><surname>Cliffe</surname></persName>
		</author>
		<idno type="DOI">10.1128/jvi.00475-22</idno>
	</analytic>
	<monogr>
		<title level="j">J. Virol</title>
		<imprint>
			<biblScope unit="page">96</biblScope>
			<date type="published" when="2022">2022</date>
		</imprint>
	</monogr>
	<note>e0047522. [CrossRef</note>
</biblStruct>

<biblStruct xml:id="b39">
	<monogr>
		<title level="m" type="main">Remyelination protects neurons from DLK-mediated neurodegeneration</title>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">J</forename><surname>Duncan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">D</forename><surname>Ingram</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Emberley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Hill</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Cordano</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Abdelhak</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Mccane</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Jabassini</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Ananth</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">J</forename><surname>Ferrara</surname></persName>
		</author>
		<idno type="DOI">10.1101/2023.09.30.560267</idno>
		<imprint/>
	</monogr>
	<note>bioRxiv 2023, ahead of print</note>
</biblStruct>

<biblStruct xml:id="b40">
	<analytic>
		<title level="a" type="main">Induced pluripotent stem cell-derived motor neurons of CMT type 2 patients reveal progressive mitochondrial dysfunction</title>
		<author>
			<persName><forename type="first">J</forename><surname>Van Lent</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Verstraelen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Asselbergh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Adriaenssens</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Mateiu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Verbist</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>De Winter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Eggermont</surname></persName>
		</author>
		<author>
			<persName><surname>Van Den</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Bosch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">H</forename><surname>De Vos</surname></persName>
		</author>
		<idno type="DOI">10.1093/brain/awab226</idno>
	</analytic>
	<monogr>
		<title level="j">Brain</title>
		<imprint>
			<biblScope unit="volume">144</biblScope>
			<biblScope unit="page" from="2471" to="2485" />
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b41">
	<analytic>
		<title level="a" type="main">Discovery of IACS-52825, a Potent and Selective DLK Inhibitor for Treatment of Chemotherapy-Induced Peripheral Neuropathy</title>
		<author>
			<persName><forename type="first">K</forename><surname>Le</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Soth</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">B</forename><surname>Cross</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">J</forename><surname>Ray</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Ma</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">G</forename><surname>Goodwani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">J</forename><surname>Acton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Buggia-Prevot</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Akkermans</surname></persName>
		</author>
		<idno type="DOI">10.1021/acs.jmedchem.3c00788</idno>
	</analytic>
	<monogr>
		<title level="j">J. Med. Chem</title>
		<imprint>
			<biblScope unit="volume">66</biblScope>
			<biblScope unit="page" from="9954" to="9971" />
			<date type="published" when="2023">2023</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b42">
	<analytic>
		<title level="a" type="main">Inhibition of dual leucine zipper kinase prevents chemotherapy-induced peripheral neuropathy and cognitive impairments</title>
		<author>
			<persName><forename type="first">J</forename><surname>Ma</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Goodwani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">J</forename><surname>Acton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Buggia-Prevot</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">R</forename><surname>Kesler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Jamal</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">D</forename><surname>Mahant</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Mseeh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">L</forename><surname>Roth</surname></persName>
		</author>
		<idno type="DOI">10.1097/j.pain.0000000000002256</idno>
	</analytic>
	<monogr>
		<title level="j">PAIN</title>
		<imprint>
			<biblScope unit="volume">2021</biblScope>
			<biblScope unit="page" from="2599" to="2612" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b43">
	<analytic>
		<title level="a" type="main">Enhanced Functional Genomic Screening Identifies Novel Mediators of Dual Leucine Zipper Kinase-Dependent Injury Signaling in Neurons</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">S</forename><surname>Welsbie</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">L</forename><surname>Mitchell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Jaskula-Ranga</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">M</forename><surname>Sluch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Yang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Buehler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Patel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">E</forename><surname>Martin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P.-W</forename><surname>Zhang</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.neuron.2017.06.008</idno>
	</analytic>
	<monogr>
		<title level="j">Neuron</title>
		<imprint>
			<biblScope unit="volume">94</biblScope>
			<biblScope unit="page" from="1142" to="1154" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b44">
	<analytic>
		<title level="a" type="main">A hypotonic gel-forming eye drop provides enhanced intraocular delivery of a kinase inhibitor with melanin-binding properties for sustained protection of retinal ganglion cells</title>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">C</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">T</forename><surname>Hsueh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">D</forename><surname>Shin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">A</forename><surname>Berlinicke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Han</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">M</forename><surname>Anders</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Hemingway</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">T</forename><surname>Leo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">T</forename><surname>Chou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Kwon</surname></persName>
		</author>
		<idno type="DOI">10.1007/s13346-021-00987-6</idno>
	</analytic>
	<monogr>
		<title level="j">Drug Deliv. Transl. Res</title>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="page" from="826" to="837" />
			<date type="published" when="2022">2022</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b45">
	<analytic>
		<title level="a" type="main">Role of SARM1 and DR6 in retinal ganglion cell axonal and somal degeneration following axonal injury</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">A</forename><surname>Fernandes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">L</forename><surname>Mitchell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Patel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><forename type="middle">J</forename><surname>Marola</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Shrager</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">J</forename><surname>Zack</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">T</forename><surname>Libby</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">S</forename><surname>Welsbie</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.exer.2018.03.007</idno>
	</analytic>
	<monogr>
		<title level="j">Exp. Eye Res</title>
		<imprint>
			<biblScope unit="volume">171</biblScope>
			<biblScope unit="page" from="54" to="61" />
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b46">
	<analytic>
		<title level="a" type="main">Identification, molecular cloning, and characterization of dual leucine zipper bearing kinase. A novel serine/threonine protein kinase that defines a second subfamily of mixed lineage kinases</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">B</forename><surname>Holzman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">E</forename><surname>Merritt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Fan</surname></persName>
		</author>
		<idno type="DOI">10.1016/S0021-9258(18)47353-X</idno>
	</analytic>
	<monogr>
		<title level="j">J. Biol. Chem</title>
		<imprint>
			<biblScope unit="volume">269</biblScope>
			<biblScope unit="page" from="30808" to="30817" />
			<date type="published" when="1994">1994</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b47">
	<analytic>
		<title level="a" type="main">Mixed-lineage kinase control of JNK and p38 MAPK pathways</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">A</forename><surname>Gallo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">L</forename><surname>Johnson</surname></persName>
		</author>
		<idno type="DOI">10.1038/nrm906</idno>
	</analytic>
	<monogr>
		<title level="j">Nat. Rev. Mol. Cell Biol</title>
		<imprint>
			<biblScope unit="volume">3</biblScope>
			<biblScope unit="page" from="663" to="672" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b48">
	<analytic>
		<title level="a" type="main">Therapeutic potential of targeting mixed lineage kinases in cancer and inflammation</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">A</forename><surname>Gallo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Ellsworth</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Stoub</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">E</forename><surname>Conrad</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.pharmthera.2019.107457</idno>
	</analytic>
	<monogr>
		<title level="j">Pharmacol. Ther</title>
		<imprint>
			<biblScope unit="volume">207</biblScope>
			<date type="published" when="2020">2020. 107457</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b49">
	<analytic>
		<title level="a" type="main">Mice lacking both mixed-lineage kinase genes Mlk1 and Mlk2 retain a wild type phenotype</title>
		<author>
			<persName><forename type="first">N</forename><surname>Bisson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Tremblay</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Robinson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">R</forename><surname>Kaplan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">P</forename><surname>Trusko</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Moss</surname></persName>
		</author>
		<idno type="DOI">10.4161/cc.7.7.5610</idno>
	</analytic>
	<monogr>
		<title level="j">Cell Cycle</title>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="page" from="909" to="916" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b50">
	<analytic>
		<title level="a" type="main">Leucine Zipper-bearing Kinase promotes axon growth in mammalian central nervous system neurons</title>
		<author>
			<persName><forename type="first">M</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">G</forename><surname>Geoffroy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">N</forename><surname>Wong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Tress</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">T</forename><surname>Nguyen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">B</forename><surname>Holzman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Jin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Zheng</surname></persName>
		</author>
		<idno type="DOI">10.1038/srep31482</idno>
	</analytic>
	<monogr>
		<title level="j">Sci. Rep</title>
		<imprint>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="page">31482</biblScope>
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b51">
	<analytic>
		<title level="a" type="main">An axonal stress response pathway: Degenerative and regenerative signaling by DLK</title>
		<author>
			<persName><forename type="first">E</forename><surname>Asghari Adib</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">J</forename><surname>Smithson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">A</forename><surname>Collins</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.conb.2018.07.002</idno>
	</analytic>
	<monogr>
		<title level="j">Curr. Opin. Neurobiol</title>
		<imprint>
			<biblScope unit="volume">53</biblScope>
			<biblScope unit="page" from="110" to="119" />
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b52">
	<analytic>
		<title level="a" type="main">DLK regulates a distinctive transcriptional regeneration program after peripheral nerve injury</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">E</forename><surname>Shin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Ha</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">K</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Cho</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Diantonio</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.nbd.2019.02.001</idno>
	</analytic>
	<monogr>
		<title level="j">Neurobiol. Dis</title>
		<imprint>
			<biblScope unit="volume">127</biblScope>
			<biblScope unit="page" from="178" to="192" />
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b53">
	<analytic>
		<title level="a" type="main">The DLK signalling pathway--a double-edged sword in neural development and regeneration</title>
		<author>
			<persName><forename type="first">A</forename><surname>Tedeschi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Bradke</surname></persName>
		</author>
		<idno type="DOI">10.1038/embor.2013.64</idno>
	</analytic>
	<monogr>
		<title level="j">EMBO Rep</title>
		<imprint>
			<biblScope unit="volume">14</biblScope>
			<biblScope unit="page" from="605" to="614" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b54">
	<analytic>
		<title level="a" type="main">Multitasking: Dual Leucine Zipper-Bearing Kinases in Neuronal Development and Stress Management</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Jin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Zheng</surname></persName>
		</author>
		<idno type="DOI">10.1146/annurev-cellbio-100617-062644</idno>
	</analytic>
	<monogr>
		<title level="j">Annu. Rev. Cell Dev. Biol</title>
		<imprint>
			<biblScope unit="volume">35</biblScope>
			<biblScope unit="page" from="501" to="521" />
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b55">
	<analytic>
		<title level="a" type="main">Mixed lineage kinase-dependent JNK activation is governed by interactions of scaffold protein JIP with MAPK module components</title>
		<author>
			<persName><forename type="first">D</forename><surname>Nihalani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Meyer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Pajni</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">B</forename><surname>Holzman</surname></persName>
		</author>
		<idno type="DOI">10.1093/emboj/20.13.3447</idno>
	</analytic>
	<monogr>
		<title level="j">EMBO J</title>
		<imprint>
			<biblScope unit="volume">20</biblScope>
			<biblScope unit="page" from="3447" to="3458" />
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b56">
	<analytic>
		<title level="a" type="main">Recruitment of JNK to JIP1 and JNK-dependent JIP1 Phosphorylation Regulates JNK Module Dynamics and Activation</title>
		<author>
			<persName><forename type="first">D</forename><surname>Nihalani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">N</forename><surname>Wong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">B</forename><surname>Holzman</surname></persName>
		</author>
		<idno type="DOI">10.1074/jbc.M304212200</idno>
	</analytic>
	<monogr>
		<title level="j">J. Biol. Chem</title>
		<imprint>
			<biblScope unit="volume">278</biblScope>
			<biblScope unit="page" from="28694" to="28702" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b57">
	<analytic>
		<title level="a" type="main">Src Family Kinases Directly Regulate JIP1 Module Dynamics and Activation</title>
		<author>
			<persName><forename type="first">D</forename><surname>Nihalani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Wong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Verma</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">B</forename><surname>Holzman</surname></persName>
		</author>
		<idno type="DOI">10.1128/MCB.01479-06</idno>
	</analytic>
	<monogr>
		<title level="j">Mol. Cell. Biol</title>
		<imprint>
			<biblScope unit="volume">27</biblScope>
			<biblScope unit="page" from="2431" to="2441" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b58">
	<analytic>
		<title level="a" type="main">DLK (Dual Leucine Zipper-Bearing Kinase)</title>
		<author>
			<persName><forename type="first">R</forename><surname>Blouin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Choi</surname></persName>
		</author>
		<author>
			<persName><surname>Ed</surname></persName>
		</author>
		<idno type="DOI">10.1007/978-3-319-67199-4_402</idno>
	</analytic>
	<monogr>
		<title level="m">Encyclopedia of Signaling Molecules</title>
		<meeting><address><addrLine>Cham, Switzerland</addrLine></address></meeting>
		<imprint>
			<publisher>Springer International Publishing</publisher>
			<date type="published" when="2018">2018</date>
			<biblScope unit="page" from="1397" to="1402" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b59">
	<analytic>
		<title level="a" type="main">SP3 acts as a positive regulator on the core promoter of human ZPK gene</title>
		<author>
			<persName><forename type="first">A</forename><surname>Itoh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Ito</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><forename type="middle">R</forename><surname>Reddy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Itoh</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.bbrc.2003.11.152</idno>
	</analytic>
	<monogr>
		<title level="j">Biochem. Biophys. Res. Commun</title>
		<imprint>
			<biblScope unit="volume">313</biblScope>
			<biblScope unit="page" from="612" to="618" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b60">
	<analytic>
		<title level="a" type="main">The DLK gene is a transcriptional target of PPARgamma</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">P</forename><surname>Couture</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Blouin</surname></persName>
		</author>
		<idno type="DOI">10.1042/BJ20101840</idno>
	</analytic>
	<monogr>
		<title level="j">Biochem. J</title>
		<imprint>
			<biblScope unit="volume">438</biblScope>
			<biblScope unit="page" from="93" to="101" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b61">
	<analytic>
		<title level="a" type="main">Bisphenol A enhances adipogenic differentiation of human adipose stromal/stem cells</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">F</forename><surname>Ohlstein</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">L</forename><surname>Strong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Mclachlan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Gimble</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">E</forename><surname>Burow</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">A</forename><surname>Bunnell</surname></persName>
		</author>
		<idno type="DOI">10.1530/JME-14-0052</idno>
	</analytic>
	<monogr>
		<title level="j">J. Mol. Endocrinol</title>
		<imprint>
			<biblScope unit="volume">53</biblScope>
			<biblScope unit="page" from="345" to="353" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b62">
	<analytic>
		<title level="a" type="main">The mixed-lineage kinase DLK is a key regulator of 3T3-L1 adipocyte differentiation</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">P</forename><surname>Couture</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Daviau</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Fradette</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Blouin</surname></persName>
		</author>
		<idno type="DOI">10.1371/journal.pone.0004743</idno>
	</analytic>
	<monogr>
		<title level="j">PLoS ONE</title>
		<imprint>
			<biblScope unit="volume">4</biblScope>
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b63">
	<analytic>
		<title level="a" type="main">Deficiency of the bZIP transcription factors Mafg and Mafk causes misexpression of genes in distinct pathways and results in lens embryonic developmental defects</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">D</forename><surname>Patel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Anand</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Motohashi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Katsuoka</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Yamamoto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">A</forename><surname>Lachke</surname></persName>
		</author>
		<idno type="DOI">10.3389/fcell.2022.981893</idno>
	</analytic>
	<monogr>
		<title level="j">Front. Cell Dev. Biol</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<date type="published" when="2022">2022. 981893</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b64">
	<analytic>
		<title level="a" type="main">Regulation of DLK-1 kinase activity by calcium-mediated dissociation from an inhibitory isoform</title>
		<author>
			<persName><forename type="first">D</forename><surname>Yan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Jin</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.neuron.2012.08.043</idno>
	</analytic>
	<monogr>
		<title level="j">Neuron</title>
		<imprint>
			<biblScope unit="volume">76</biblScope>
			<biblScope unit="page" from="534" to="548" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b65">
	<analytic>
		<title level="a" type="main">Sung Wook, C. MicroRNA Target Recognition: Insights from Transcriptome-Wide Non-Canonical Interactions</title>
		<author>
			<persName><forename type="first">S</forename><surname>Heeyoung</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Juyoung</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Eun-Sook</surname></persName>
		</author>
		<idno type="DOI">10.14348/molcells.2016.0013</idno>
	</analytic>
	<monogr>
		<title level="j">Mol. Cells</title>
		<imprint>
			<biblScope unit="volume">39</biblScope>
			<biblScope unit="page" from="375" to="381" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b66">
	<monogr>
		<title level="m" type="main">Predicting effective microRNA target sites in mammalian mRNAs</title>
		<author>
			<persName><forename type="first">V</forename><surname>Agarwal</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">W</forename><surname>Bell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J.-W</forename><surname>Nam</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">P</forename><surname>Bartel</surname></persName>
		</author>
		<idno type="DOI">10.7554/eLife.05005</idno>
		<imprint>
			<date type="published" when="2015">2015, 4, e05005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b67">
	<analytic>
		<title level="a" type="main">miRTarBase update 2022: An informative resource for experimentally validated miRNA-target interactions</title>
		<author>
			<persName><forename type="first">H.-Y</forename><surname>Huang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y.-C.-D</forename><surname>Lin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Cui</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Huang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Tang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Xu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Bao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Wen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Zuo</surname></persName>
		</author>
		<idno type="DOI">10.1093/nar/gkab1079</idno>
		<idno>222-D230</idno>
	</analytic>
	<monogr>
		<title level="j">Nucleic Acids Res</title>
		<imprint>
			<biblScope unit="volume">50</biblScope>
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b68">
	<analytic>
		<title level="a" type="main">Down-regulation of miR-17 family expression in response to retinoic acid induced neuronal differentiation</title>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">J</forename><surname>Beveridge</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">A</forename><surname>Tooney</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">P</forename><surname>Carroll</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Tran</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Cairns</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.cellsig.2009.07.019</idno>
	</analytic>
	<monogr>
		<title level="j">Cell. Signal</title>
		<imprint>
			<biblScope unit="volume">21</biblScope>
			<biblScope unit="page" from="1837" to="1845" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b69">
	<analytic>
		<title level="a" type="main">MicroRNA-130a Targets MAP3K12 to Modulate Diabetic Endothelial Progenitor Cell Function</title>
		<author>
			<persName><forename type="first">M</forename><surname>Ye</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Yang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Xie</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Yu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Ma</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Zhu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Zhao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Lv</surname></persName>
		</author>
		<idno type="DOI">10.1159/000430132</idno>
	</analytic>
	<monogr>
		<title level="j">Cell. Physiol. Biochem</title>
		<imprint>
			<biblScope unit="volume">36</biblScope>
			<biblScope unit="page" from="712" to="726" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b70">
	<analytic>
		<title level="a" type="main">Aryl hydrocarbon receptor enhances the expression of miR-150-5p to suppress in prostate cancer progression by regulating MAP3K12</title>
		<author>
			<persName><forename type="first">J</forename><surname>Yu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Feng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>An</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.abb.2018.07.010</idno>
	</analytic>
	<monogr>
		<title level="j">Arch. Biochem. Biophys</title>
		<imprint>
			<biblScope unit="volume">654</biblScope>
			<biblScope unit="page" from="47" to="54" />
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b71">
	<analytic>
		<title level="a" type="main">Characterization of Dual Leucine Zipper-bearing Kinase, a Mixed Lineage Kinase Present in Synaptic Terminals Whose Phosphorylation State Is Regulated by Membrane Depolarization via Calcineurin</title>
		<author>
			<persName><forename type="first">M</forename><surname>Mata</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">E</forename><surname>Merritt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Fan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">G</forename><surname>Yu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">B</forename><surname>Holzman</surname></persName>
		</author>
		<idno type="DOI">10.1074/jbc.271.28.16888</idno>
	</analytic>
	<monogr>
		<title level="j">J. Biol. Chem</title>
		<imprint>
			<biblScope unit="volume">271</biblScope>
			<biblScope unit="page" from="16888" to="16896" />
			<date type="published" when="1996">1996</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b72">
	<analytic>
		<title level="a" type="main">JNK-mediated phosphorylation of DLK suppresses its ubiquitination to promote neuronal apoptosis</title>
		<author>
			<persName><forename type="first">S</forename><surname>Huntwork-Rodriguez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Watkins</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">S</forename><surname>Ghosh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">D</forename><surname>Pozniak</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Bustos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Newton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">S</forename><surname>Kirkpatrick</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">W</forename><surname>Lewcock</surname></persName>
		</author>
		<idno type="DOI">10.1083/jcb.201303066</idno>
	</analytic>
	<monogr>
		<title level="j">J. Cell Biol</title>
		<imprint>
			<biblScope unit="volume">202</biblScope>
			<biblScope unit="page" from="747" to="763" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b73">
	<monogr>
		<title level="m" type="main">An evolutionarily conserved mechanism for cAMP elicited axonal regeneration involves direct activation of the dual leucine zipper kinase DLK</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Hao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Frey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Yoon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Wong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Nestorovski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">B</forename><surname>Holzman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">J</forename><surname>Giger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Diantonio</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Collins</surname></persName>
		</author>
		<idno type="DOI">10.7554/eLife.14048</idno>
		<imprint>
			<date type="published" when="2016">2016. 14048</date>
			<biblScope unit="volume">5</biblScope>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b74">
	<analytic>
		<title level="a" type="main">Calcium and Cyclic AMP Promote Axonal Regeneration in Caenorhabditis elegans and Require DLK-1 Kinase</title>
		<author>
			<persName><forename type="first">A</forename><surname>Ghosh-Roy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Wu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Goncharov</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Jin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">D</forename><surname>Chisholm</surname></persName>
		</author>
		<idno type="DOI">10.1523/JNEUROSCI.5464-09.2010</idno>
	</analytic>
	<monogr>
		<title level="j">J. Neurosci</title>
		<imprint>
			<biblScope unit="volume">30</biblScope>
			<biblScope unit="page" from="3175" to="3183" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b75">
	<analytic>
		<title level="a" type="main">Inhibition of GCK-IV kinases dissociates cell death and axon regeneration in CNS neurons</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">K</forename><surname>Patel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">M</forename><surname>Broyer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">D</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Lu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Louie</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>La Torre</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Al-Ali</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">T</forename><surname>Vu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">L</forename><surname>Mitchell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">J</forename><surname>Wahlin</surname></persName>
		</author>
		<idno type="DOI">10.1073/pnas.2004683117</idno>
	</analytic>
	<monogr>
		<title level="j">Proc. Natl. Acad. Sci</title>
		<imprint>
			<biblScope unit="volume">117</biblScope>
			<biblScope unit="page" from="33597" to="33607" />
			<date type="published" when="2020">2020</date>
			<pubPlace>USA</pubPlace>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b76">
	<analytic>
		<title level="a" type="main">Human HPK1, a novel human hematopoietic progenitor kinase that activates the JNK/SAPK kinase cascade</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename><surname>Hu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">R</forename><surname>Qiu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">F</forename><surname>Meyer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">H</forename><surname>Tan</surname></persName>
		</author>
		<idno type="DOI">10.1101/gad.10.18.2251</idno>
	</analytic>
	<monogr>
		<title level="j">Genes Dev</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="page" from="2251" to="2264" />
			<date type="published" when="1996">1996</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b77">
	<analytic>
		<title level="a" type="main">The Kinase Activation Loop Is the Key to Mixed Lineage Kinase-3 Activation via Both Autophosphorylation and Hematopoetic Progenitor Kinase 1 Phosphorylation*</title>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">W</forename><surname>Leung</surname></persName>
		</author>
		<author>
			<persName><forename type="first">-L</forename><surname>Lassam</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename></persName>
		</author>
		<idno type="DOI">10.1074/jbc.M004092200</idno>
	</analytic>
	<monogr>
		<title level="j">J. Biol. Chem</title>
		<imprint>
			<biblScope unit="volume">276</biblScope>
			<biblScope unit="page" from="1961" to="1967" />
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b78">
	<analytic>
		<title level="a" type="main">HSP90 is a chaperone for DLK and is required for axon injury signaling</title>
		<author>
			<persName><forename type="first">S</forename><surname>Karney-Grobe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Russo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Frey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Milbrandt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Diantonio</surname></persName>
		</author>
		<idno type="DOI">10.1073/pnas.1805351115</idno>
	</analytic>
	<monogr>
		<title level="j">Proc. Natl. Acad. Sci</title>
		<imprint>
			<biblScope unit="volume">115</biblScope>
			<date type="published" when="2018">2018</date>
			<pubPlace>USA</pubPlace>
		</imprint>
	</monogr>
	<note>E9899-E9908. [CrossRef</note>
</biblStruct>

<biblStruct xml:id="b79">
	<analytic>
		<title level="a" type="main">Downregulation of the mixed-lineage dual leucine zipper-bearing kinase by heat shock protein 70 and its co-chaperone CHIP</title>
		<author>
			<persName><forename type="first">A</forename><surname>Daviau</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Proulx</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Robitaille</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Di Fruscio</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">M</forename><surname>Tanguay</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Landry</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Patterson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Durocher</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Blouin</surname></persName>
		</author>
		<idno type="DOI">10.1074/jbc.M607612200</idno>
	</analytic>
	<monogr>
		<title level="j">J. Biol. Chem</title>
		<imprint>
			<biblScope unit="volume">281</biblScope>
			<biblScope unit="page" from="31467" to="31477" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b80">
	<analytic>
		<title level="a" type="main">FK506-binding protein-like and FK506-binding protein 8 regulate dual leucine zipper kinase degradation and neuronal responses to axon injury</title>
		<author>
			<persName><forename type="first">B</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Oh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Cho</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Diantonio</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Cavalli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">E</forename><surname>Shin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">W</forename><surname>Choi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Cho</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.jbc.2022.101647</idno>
	</analytic>
	<monogr>
		<title level="j">J. Biol. Chem</title>
		<imprint>
			<biblScope unit="volume">298</biblScope>
			<date type="published" when="2022">2022. 101647</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b81">
	<analytic>
		<title level="a" type="main">Palmitoylation controls DLK localization, interactions and activity to ensure effective axonal injury signaling</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">M</forename><surname>Holland</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">M</forename><surname>Collura</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Ketschek</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Noma</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">A</forename><surname>Ferguson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Jin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Gallo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">M</forename><surname>Thomas</surname></persName>
		</author>
		<idno type="DOI">10.1073/pnas.1514123113</idno>
	</analytic>
	<monogr>
		<title level="j">Proc. Natl. Acad. Sci</title>
		<imprint>
			<biblScope unit="volume">113</biblScope>
			<biblScope unit="page" from="763" to="768" />
			<date type="published" when="2016">2016</date>
			<pubPlace>USA</pubPlace>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b82">
	<analytic>
		<title level="a" type="main">The mixed-lineage kinase DLK undergoes Src-dependent tyrosine phosphorylation and activation in cells exposed to vanadate or platelet-derived growth factor (PDGF)</title>
		<author>
			<persName><forename type="first">A</forename><surname>Daviau</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Di Fruscio</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Blouin</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.cellsig.2008.12.009</idno>
	</analytic>
	<monogr>
		<title level="j">Cell. Signal</title>
		<imprint>
			<biblScope unit="volume">21</biblScope>
			<biblScope unit="page" from="577" to="587" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b83">
	<analytic>
		<title level="a" type="main">Akt suppresses DLK for maintaining self-renewal of mouse embryonic stem cells</title>
		<author>
			<persName><forename type="first">C.-C</forename><surname>Wu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H.-J</forename><surname>Wu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C.-H</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C.-H</forename><surname>Lin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S.-C</forename><surname>Hsu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y.-R</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Hsiao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">C</forename><surname>Schuyler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">L</forename><surname>Lu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Ma</surname></persName>
		</author>
		<idno type="DOI">10.1080/15384101.2015.1014144</idno>
	</analytic>
	<monogr>
		<title level="j">Cell Cycle</title>
		<imprint>
			<biblScope unit="volume">14</biblScope>
			<biblScope unit="page" from="1207" to="1217" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b84">
	<analytic>
		<title level="a" type="main">PPM-1, a PP2Cα/β phosphatase, Regulates Axon Termination and Synapse Formation in Caenorhabditis elegans</title>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">D</forename><surname>Tulgren</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">T</forename><surname>Baker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Rapp</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Gurney</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Grill</surname></persName>
		</author>
		<idno type="DOI">10.1534/genetics.111.134791</idno>
	</analytic>
	<monogr>
		<title level="j">Genetics</title>
		<imprint>
			<biblScope unit="volume">189</biblScope>
			<biblScope unit="page" from="1297" to="1307" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b85">
	<analytic>
		<title level="a" type="main">RPM-1 Uses Both Ubiquitin Ligase and Phosphatase-Based Mechanisms to Regulate DLK-1 during Neuronal Development</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">T</forename><surname>Baker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">J</forename><surname>Opperman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">D</forename><surname>Tulgren</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">M</forename><surname>Turgeon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Bienvenut</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Grill</surname></persName>
		</author>
		<idno type="DOI">10.1371/journal.pgen.1004297</idno>
	</analytic>
	<monogr>
		<title level="j">PLoS Genet</title>
		<imprint>
			<date type="published" when="2014">2014, 10, e1004297</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b86">
	<analytic>
		<title level="a" type="main">Inhibition of membrane depolarisation-induced transcriptional activity of cyclic AMP response element binding protein (CREB) by the dual-leucine-zipper-bearing kinase in a pancreatic islet beta cell line</title>
		<author>
			<persName><forename type="first">E</forename><surname>Oetjen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Lechleiter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Blume</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Nihalani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Holzman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Knepel</surname></persName>
		</author>
		<idno type="DOI">10.1007/s00125-005-0087-1</idno>
	</analytic>
	<monogr>
		<title level="j">Diabetologia</title>
		<imprint>
			<biblScope unit="volume">49</biblScope>
			<biblScope unit="page" from="332" to="342" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b87">
	<analytic>
		<author>
			<persName><forename type="first">D'</forename><surname>Souza</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Hendricks</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Le Guyader</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Subburaju</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Grunewald</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Scholich</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Jesuthasan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename></persName>
		</author>
		<idno type="DOI">10.1242/dev.01578</idno>
	</analytic>
	<monogr>
		<title level="m">Formation of the retinotectal projection requires Esrom, an ortholog of PAM (protein associated with Myc)</title>
		<imprint>
			<date type="published" when="2005">2005</date>
			<biblScope unit="volume">132</biblScope>
			<biblScope unit="page" from="247" to="256" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b88">
	<analytic>
		<title level="a" type="main">The Ubiquitin Ligase Phr1 Regulates Axon Outgrowth through Modulation of Microtubule Dynamics</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">W</forename><surname>Lewcock</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Genoud</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Lettieri</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">L</forename><surname>Pfaff</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.neuron.2007.09.009</idno>
	</analytic>
	<monogr>
		<title level="j">Neuron</title>
		<imprint>
			<biblScope unit="volume">56</biblScope>
			<biblScope unit="page" from="604" to="620" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b89">
	<analytic>
		<title level="a" type="main">Axon Regeneration Requires a Conserved MAP Kinase Pathway</title>
		<author>
			<persName><forename type="first">M</forename><surname>Hammarlund</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Nix</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Hauth</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">M</forename><surname>Jorgensen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Bastiani</surname></persName>
		</author>
		<idno type="DOI">10.1126/science.1165527</idno>
	</analytic>
	<monogr>
		<title level="j">Science</title>
		<imprint>
			<biblScope unit="volume">323</biblScope>
			<biblScope unit="page" from="802" to="806" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b90">
	<analytic>
		<title level="a" type="main">An SCF-like ubiquitin ligase complex that controls presynaptic differentiation</title>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">H</forename><surname>Liao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Hung</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Abrams</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Zhen</surname></persName>
		</author>
		<idno type="DOI">10.1038/nature02647</idno>
	</analytic>
	<monogr>
		<title level="j">Nature</title>
		<imprint>
			<biblScope unit="volume">430</biblScope>
			<biblScope unit="page" from="345" to="350" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b91">
	<analytic>
		<title level="a" type="main">Regulation of a DLK-1 and p38 MAP Kinase Pathway by the Ubiquitin Ligase RPM-1 Is Required for Presynaptic Development</title>
		<author>
			<persName><forename type="first">K</forename><surname>Nakata</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Abrams</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Grill</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Goncharov</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Huang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">D</forename><surname>Chisholm</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Jin</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.cell.2004.12.017</idno>
	</analytic>
	<monogr>
		<title level="j">Cell</title>
		<imprint>
			<biblScope unit="volume">120</biblScope>
			<biblScope unit="page" from="407" to="420" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b92">
	<analytic>
		<title level="a" type="main">A Family of Stress-Inducible GADD45-like Proteins Mediate Activation of the Stress-Responsive MTK1/MEKK4 MAPKKK</title>
		<author>
			<persName><forename type="first">M</forename><surname>Takekawa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Saito</surname></persName>
		</author>
		<idno type="DOI">10.1016/S0092-8674(00)81619-0</idno>
	</analytic>
	<monogr>
		<title level="j">Cell</title>
		<imprint>
			<biblScope unit="volume">95</biblScope>
			<biblScope unit="page" from="521" to="530" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b93">
	<analytic>
		<title level="a" type="main">Loss of the Spectraplakin Short Stop Activates the DLK Injury Response Pathway in Drosophila</title>
		<author>
			<persName><forename type="first">V</forename><surname>Valakh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">J</forename><surname>Walker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">B</forename><surname>Skeath</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Diantonio</surname></persName>
		</author>
		<idno type="DOI">10.1523/JNEUROSCI.2196-13.2013</idno>
	</analytic>
	<monogr>
		<title level="j">J. Neurosci</title>
		<imprint>
			<biblScope unit="volume">33</biblScope>
			<biblScope unit="page" from="17863" to="17873" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b94">
	<analytic>
		<title level="a" type="main">Cytoskeletal disruption activates the DLK/JNK pathway, which promotes axonal regeneration and mimics a preconditioning injury</title>
		<author>
			<persName><forename type="first">V</forename><surname>Valakh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Frey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Babetto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">J</forename><surname>Walker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Diantonio</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.nbd.2015.02.014</idno>
	</analytic>
	<monogr>
		<title level="j">Neurobiol. Dis</title>
		<imprint>
			<biblScope unit="volume">77</biblScope>
			<biblScope unit="page" from="13" to="25" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b95">
	<analytic>
		<title level="a" type="main">Protein phosphatase 2A: A highly regulated family of serine/threonine phosphatases implicated in cell growth and signalling</title>
		<author>
			<persName><forename type="first">V</forename><surname>Janssens</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Goris</surname></persName>
		</author>
		<idno type="DOI">10.1042/bj3530417</idno>
	</analytic>
	<monogr>
		<title level="j">Biochem. J</title>
		<imprint>
			<biblScope unit="volume">353</biblScope>
			<biblScope unit="page" from="417" to="439" />
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b96">
	<analytic>
		<title level="a" type="main">A conserved docking surface on calcineurin mediates interaction with substrates and immunosuppressants</title>
		<author>
			<persName><forename type="first">A</forename><surname>Rodriguez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Roy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Martinez-Martinez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">D</forename><surname>Lopez-Maderuelo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Nino-Moreno</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Orti</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Pantoja-Uceda</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Pineda-Lucena</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">S</forename><surname>Cyert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Redondo</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.molcel.2009.01.030</idno>
	</analytic>
	<monogr>
		<title level="j">Mol. Cell</title>
		<imprint>
			<biblScope unit="volume">33</biblScope>
			<biblScope unit="page" from="616" to="626" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b97">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">H</forename><surname>Ahmed</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Biddle</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Augustine</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Azmi</surname></persName>
		</author>
		<imprint>
			<date type="published" when="2020">2020</date>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="page" from="779" to="801" />
		</imprint>
	</monogr>
	<note type="report_type">Post-Transplantation Diabetes Mellitus. Diabetes Ther</note>
</biblStruct>

<biblStruct xml:id="b98">
	<analytic>
		<title level="a" type="main">Post-translational palmitoylation of metabolic proteins</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">M J H</forename><surname>Dennis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">C</forename><surname>Heather</surname></persName>
		</author>
		<idno type="DOI">10.3389/fphys.2023.1122895</idno>
	</analytic>
	<monogr>
		<title level="j">Front. Physiol</title>
		<imprint>
			<biblScope unit="volume">14</biblScope>
			<date type="published" when="2023">2023. 1122895</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b99">
	<analytic>
		<title level="a" type="main">Palmitoylation couples the kinases DLK and JNK3 to facilitate prodegenerative axon-to-soma signaling</title>
		<author>
			<persName><forename type="first">J</forename><surname>Niu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">M</forename><surname>Holland</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Ketschek</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">M</forename><surname>Collura</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">L</forename><surname>Hesketh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Hayashi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Gallo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">M</forename><surname>Thomas</surname></persName>
		</author>
		<idno type="DOI">10.1126/scisignal.abh2674</idno>
	</analytic>
	<monogr>
		<title level="j">Sci. Signal</title>
		<imprint>
			<biblScope unit="page" from="15" to="2674" />
			<date type="published" when="2022">2022</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b100">
	<analytic>
		<title level="a" type="main">Stress-induced vesicular assemblies of dual leucine zipper kinase are signaling hubs involved in kinase activation and neurodegeneration</title>
		<author>
			<persName><forename type="first">E</forename><surname>Tortosa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Sengupta Ghosh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Q</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">R</forename><surname>Wong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Hinkle</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Sandoval</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">M</forename><surname>Rose</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">C</forename><surname>Hoogenraad</surname></persName>
		</author>
		<idno type="DOI">10.15252/embj.2021110155</idno>
	</analytic>
	<monogr>
		<title level="j">EMBO J</title>
		<imprint>
			<biblScope unit="page">41</biblScope>
			<date type="published" when="2022">2022. 110155</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b101">
	<analytic>
		<title level="a" type="main">Identification of Novel Inhibitors of DLK Palmitoylation and Signaling by High Content Screening</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">D O</forename><surname>Martin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">S</forename><surname>Kanuparthi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">M</forename><surname>Holland</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">S</forename><surname>Sanders</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H.-K</forename><surname>Jeong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">B</forename><surname>Einarson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Jacobson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">M</forename><surname>Thomas</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Sci. Rep</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="page">3632</biblScope>
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b102">
	<analytic>
		<title level="a" type="main">Coupled Control of Distal Axon Integrity and Somal Responses to Axonal Damage by the Palmitoyl Acyltransferase ZDHHC17</title>
		<author>
			<persName><forename type="first">J</forename><surname>Niu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">S</forename><surname>Sanders</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H.-K</forename><surname>Jeong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">M</forename><surname>Holland</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Sun</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">M</forename><surname>Collura</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">M</forename><surname>Hernandez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Huang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">R</forename><surname>Hayden</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">M</forename><surname>Smith</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.celrep.2020.108365</idno>
	</analytic>
	<monogr>
		<title level="j">Cell Rep</title>
		<imprint>
			<biblScope unit="volume">33</biblScope>
			<date type="published" when="2020">2020. 108365</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b103">
	<analytic>
		<title level="a" type="main">The PHR proteins: Intracellular signaling hubs in neuronal development and axon degeneration</title>
		<author>
			<persName><forename type="first">B</forename><surname>Grill</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">K</forename><surname>Murphey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Borgen</surname></persName>
		</author>
		<idno type="DOI">10.1186/s13064-016-0063-0</idno>
	</analytic>
	<monogr>
		<title level="j">Neural Dev</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b104">
	<analytic>
		<title level="a" type="main">Docking Interactions in the c-Jun N-terminal Kinase Pathway</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">M</forename><surname>Mooney</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">J</forename><surname>Whitmarsh</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Biol. Chem</title>
		<imprint>
			<biblScope unit="volume">279</biblScope>
			<biblScope unit="page" from="11843" to="11852" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b105">
	<analytic>
		<title level="a" type="main">POSH acts as a scaffold for a multiprotein complex that mediates JNK activation in apoptosis</title>
		<author>
			<persName><forename type="first">Z</forename><surname>Xu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">V</forename><surname>Kukekov</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">A</forename><surname>Greene</surname></persName>
		</author>
		<idno type="DOI">10.1093/emboj/cdg021</idno>
	</analytic>
	<monogr>
		<title level="j">EMBO J</title>
		<imprint>
			<biblScope unit="volume">22</biblScope>
			<biblScope unit="page" from="252" to="261" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b106">
	<analytic>
		<title level="a" type="main">HSP90 at the hub of protein homeostasis: Emerging mechanistic insights</title>
		<author>
			<persName><forename type="first">M</forename><surname>Taipale</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">F</forename><surname>Jarosz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Lindquist</surname></persName>
		</author>
		<idno type="DOI">10.1038/nrm2918</idno>
	</analytic>
	<monogr>
		<title level="j">Nat. Rev. Mol. Cell Biol</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="page" from="515" to="528" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b107">
	<analytic>
		<title level="a" type="main">The cochaperone CHIP marks Hsp70-and Hsp90-bound substrates for degradation through a very flexible mechanism</title>
		<author>
			<persName><forename type="first">L</forename><surname>Quintana-Gallardo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Martín-Benito</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Marcilla</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Espadas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Sabidó</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Valpuesta</surname></persName>
		</author>
		<idno type="DOI">10.1038/s41598-019-41060-0</idno>
	</analytic>
	<monogr>
		<title level="j">Sci. Rep</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="page">5102</biblScope>
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b108">
	<analytic>
		<title level="a" type="main">The Mixed Lineage Kinase DLK Is Oligomerized by Tissue Transglutaminase during Apoptosis</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">S</forename><surname>Hébert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Daviau</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Grondin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Latreille</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">A</forename><surname>Aubin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Blouin</surname></persName>
		</author>
		<idno type="DOI">10.1074/jbc.M006528200</idno>
	</analytic>
	<monogr>
		<title level="j">J. Biol. Chem</title>
		<imprint>
			<biblScope unit="volume">275</biblScope>
			<biblScope unit="page" from="32482" to="32490" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b109">
	<analytic>
		<title level="a" type="main">Tissue transglutaminase triggers oligomerization and activation of dual leucine zipper-bearing kinase in calphostin C-treated cells to facilitate apoptosis</title>
		<author>
			<persName><forename type="first">K</forename><surname>Robitaille</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Daviau</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Tucholski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">V W</forename><surname>Johnson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Rancourt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Blouin</surname></persName>
		</author>
		<idno type="DOI">10.1038/sj.cdd.4401392</idno>
	</analytic>
	<monogr>
		<title level="j">Cell Death Differ</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="page" from="542" to="549" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b110">
	<analytic>
		<title level="a" type="main">Calphostin C-induced apoptosis is mediated by a tissue transglutaminase-dependent mechanism involving the DLK/JNK signaling pathway</title>
		<author>
			<persName><forename type="first">K</forename><surname>Robitaille</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Daviau</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Lachance</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">P</forename><surname>Couture</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Blouin</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cell Death Differ</title>
		<imprint>
			<biblScope unit="volume">15</biblScope>
			<biblScope unit="page" from="1522" to="1531" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b111">
	<analytic>
		<title level="a" type="main">Regulation of the CREB coactivator TORC by the dual leucine zipper kinase at different levels</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">T</forename><surname>Phu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Wallbach</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Depatie</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Fu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">A</forename><surname>Screaton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Oetjen</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.cellsig.2010.10.001</idno>
	</analytic>
	<monogr>
		<title level="j">Cell. Signal</title>
		<imprint>
			<biblScope unit="volume">23</biblScope>
			<biblScope unit="page" from="344" to="353" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b112">
	<monogr>
		<title level="m" type="main">The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods</title>
		<imprint>
			<publisher>Disclaimer/Publisher&apos;s Note</publisher>
		</imprint>
	</monogr>
	<note>instructions or products referred to in the content</note>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
